{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T02:28:55Z","timestamp":1793413735922,"version":"4.5.0"},"reference-count":415,"publisher":"MDPI AG","issue":"23","license":[{"start":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T00:00:00Z","timestamp":1669334400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"ShanghaiTech and Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31871039"],"award-info":[{"award-number":["31871039"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"ShanghaiTech and Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32170962"],"award-info":[{"award-number":["32170962"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Parkinson\u2019s disease (PD) is a progressive neurodegenerative disorder. The classical behavioral defects of PD patients involve motor symptoms such as bradykinesia, tremor, and rigidity, as well as non-motor symptoms such as anosmia, depression, and cognitive impairment. Pathologically, the progressive loss of dopaminergic (DA) neurons in the substantia nigra (SN) and the accumulation of \u03b1-synuclein (\u03b1-syn)-composed Lewy bodies (LBs) and Lewy neurites (LNs) are key hallmarks. Glia are more than mere bystanders that simply support neurons, they actively contribute to almost every aspect of neuronal development and function; glial dysregulation has been implicated in a series of neurodegenerative diseases including PD. Importantly, amounting evidence has added glial activation and neuroinflammation as new features of PD onset and progression. Thus, gaining a better understanding of glia, especially neuron-glia crosstalk, will not only provide insight into brain physiology events but also advance our knowledge of PD pathologies. This review addresses the current understanding of \u03b1-syn pathogenesis in PD, with a focus on neuron-glia crosstalk. Particularly, the transmission of \u03b1-syn between neurons and glia, \u03b1-syn-induced glial activation, and feedbacks of glial activation on DA neuron degeneration are thoroughly discussed. In addition, \u03b1-syn aggregation, iron deposition, and glial activation in regulating DA neuron ferroptosis in PD are covered. Lastly, we summarize the preclinical and clinical therapies, especially targeting glia, in PD treatments.<\/jats:p>","DOI":"10.3390\/ijms232314753","type":"journal-article","created":{"date-parts":[[2022,11,28]],"date-time":"2022-11-28T01:58:46Z","timestamp":1669600726000},"page":"14753","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":92,"title":["Pathogenesis of \u03b1-Synuclein in Parkinson\u2019s Disease: From a Neuron-Glia Crosstalk Perspective"],"prefix":"10.3390","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9890-6825","authenticated-orcid":false,"given":"Shuanglong","family":"Yi","sequence":"first","affiliation":[{"name":"School of Life Science and Technology, ShanghaiTech University, Shanghai 201210, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7647-0696","authenticated-orcid":false,"given":"Linfang","family":"Wang","sequence":"additional","affiliation":[{"name":"School of Life Science and Technology, ShanghaiTech University, Shanghai 201210, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2764-8988","authenticated-orcid":false,"given":"Honglei","family":"Wang","sequence":"additional","affiliation":[{"name":"School of Life Science and Technology, ShanghaiTech University, Shanghai 201210, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2387-7564","authenticated-orcid":false,"given":"Margaret S.","family":"Ho","sequence":"additional","affiliation":[{"name":"School of Life Science and Technology, ShanghaiTech University, Shanghai 201210, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5706-0931","authenticated-orcid":false,"given":"Shiping","family":"Zhang","sequence":"additional","affiliation":[{"name":"School of Life Science and Technology, ShanghaiTech University, Shanghai 201210, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,11,25]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1176\/jnp.14.2.223","article-title":"An essay on the shaking palsy, 1817","volume":"14","author":"Parkinson","year":"2002","journal-title":"J. Neuropsychiatry Clin. Neurosci."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s41531-018-0058-0","article-title":"Prevalence of Parkinson\u2019s disease across North America","volume":"4","author":"Marras","year":"2018","journal-title":"npj Park. Dis."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1212\/WNL.45.12.2143","article-title":"Prevalence of Parkinson\u2019s disease in the elderly: The Rotterdam Study","volume":"45","author":"Breteler","year":"1995","journal-title":"Neurology"},{"key":"ref_4","first-page":"59","article-title":"L-dopa therapy in Parkinson\u2019s disease: A critical review of nine years\u2019 experience","volume":"101","author":"Barbeau","year":"1969","journal-title":"Can. Med. Assoc. J."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1002\/mds.26424","article-title":"MDS clinical diagnostic criteria for Parkinson\u2019s disease","volume":"30","author":"Postuma","year":"2015","journal-title":"Mov. Disord."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1053\/scnp.2003.50006","article-title":"Dementia with Lewy bodies","volume":"8","author":"McKeith","year":"2003","journal-title":"Semin. Clin. Neuropsychiatry"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","article-title":"Staging of brain pathology related to sporadic Parkinson\u2019s disease","volume":"24","author":"Braak","year":"2003","journal-title":"Neurobiol. Aging"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Riederer, P., Reichmann, H., Youdim, M.B.H., and Gerlach, M. (2006). Pathology associated with sporadic Parkinson\u2019s disease\u2014Where does it end?. Parkinson\u2019s Disease and Related Disorders, Springer.","DOI":"10.1007\/978-3-211-45295-0"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1146\/annurev.biochem.74.082803.133400","article-title":"The biochemistry of Parkinson\u2019s disease","volume":"74","author":"Cookson","year":"2005","journal-title":"Annu. Rev. Biochem."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.neurobiolaging.2010.05.021","article-title":"Neuroprotection of kaempferol by autophagy in models of rotenone-mediated acute toxicity: Possible implications for Parkinson\u2019s disease","volume":"33","author":"Filomeni","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"ref_11","first-page":"S9","article-title":"The search for environmental causes of Parkinson\u2019s disease: Moving forward","volume":"8","author":"Chen","year":"2018","journal-title":"J. Park. Dis."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","article-title":"Mutation in the alpha-synuclein gene identified in families with Parkinson\u2019s disease","volume":"276","author":"Polymeropoulos","year":"1997","journal-title":"Science"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Haywood, A.F., and Staveley, B.E. (2004). Parkin counteracts symptoms in a Drosophila model of Parkinson\u2019s disease. BMC Neurosci., 5.","DOI":"10.1186\/1471-2202-5-14"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/nrn2935","article-title":"The role of leucine-rich repeat kinase 2 (LRRK2) in Parkinson\u2019s disease","volume":"11","author":"Cookson","year":"2010","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1038\/nature04779","article-title":"Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin","volume":"441","author":"Clark","year":"2006","journal-title":"Nature"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"31380","DOI":"10.1038\/srep31380","article-title":"Parkinson disease-linked GBA mutation effects reversed by molecular chaperones in human cell and fly models","volume":"6","author":"Beavan","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.ajhg.2011.06.001","article-title":"VPS35 mutations in Parkinson disease","volume":"89","author":"Wider","year":"2011","journal-title":"Am. J. Hum. Genet."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1016\/j.cub.2005.07.064","article-title":"Drosophila DJ-1 mutants are selectively sensitive to environmental toxins associated with Parkinson\u2019s disease","volume":"15","author":"Meulener","year":"2005","journal-title":"Curr. Biol."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Pierce, S., and Coetzee, G.A. (2017). Parkinson\u2019s disease-associated genetic variation is linked to quantitative expression of inflammatory genes. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0175882"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1002\/glia.23115","article-title":"The glia of the adult, D.rosophila nervous system","volume":"65","author":"Kremer","year":"2017","journal-title":"Glia"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1080\/01677063.2018.1464568","article-title":"Glia: From \u2018just glue\u2019 to essential players in complex nervous systems: A comparative view from flies to mammals","volume":"32","year":"2018","journal-title":"J. Neurogenet."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1126\/science.298.5593.556","article-title":"New insights into neuron-glia communication","volume":"298","author":"Fields","year":"2002","journal-title":"Science"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1146\/annurev-neuro-070918-050306","article-title":"Neuron-Glia Signaling in Synapse Elimination","volume":"42","author":"Wilton","year":"2019","journal-title":"Annu. Rev. Neurosci."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1007\/s12264-014-1448-2","article-title":"Glial cells in neuronal development: Recent advances and insights from Drosophila melanogaster","volume":"30","author":"Ou","year":"2014","journal-title":"Neurosci. Bull."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"e2020098118","DOI":"10.1073\/pnas.2020098118","article-title":"Glia-derived temporal signals orchestrate neurogenesis in the Drosophila mushroom body","volume":"118","author":"Yang","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.neuron.2008.10.013","article-title":"The mystery and magic of glia: A perspective on their roles in health and disease","volume":"60","author":"Barres","year":"2008","journal-title":"Neuron"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.tins.2004.09.001","article-title":"Neurons and glia: Team players in axon guidance","volume":"27","author":"Chotard","year":"2004","journal-title":"Trends Neurosci."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.cell.2005.07.029","article-title":"Moody encodes two GPCRs that regulate cocaine behaviors and blood-brain barrier permeability in Drosophila","volume":"123","author":"Bainton","year":"2005","journal-title":"Cell"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S1937-6448(10)83003-5","article-title":"Axonal ensheathment and intercellular barrier formation in Drosophila","volume":"283","author":"Blauth","year":"2010","journal-title":"Int. Rev. Cell Mol. Biol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/nature09612","article-title":"Regulation of synaptic connectivity by glia","volume":"468","author":"Eroglu","year":"2010","journal-title":"Nature"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"pdb-top067587","DOI":"10.1101\/pdb.top067587","article-title":"Analysis of glial cell development and function in Drosophila","volume":"2012","author":"Stork","year":"2012","journal-title":"Cold Spring Harb. Protoc."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"3805","DOI":"10.1242\/dev.129304","article-title":"Glia in mammalian development and disease","volume":"142","author":"Zuchero","year":"2015","journal-title":"Development"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1111\/tra.12866","article-title":"A LRRK2\/dLRRK-mediated lysosomal pathway that contributes to glial cell death and DA neuron survival","volume":"23","author":"Wang","year":"2022","journal-title":"Traffic"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1093\/brain\/awh054","article-title":"The expression of DJ-1 (PARK7) in normal human CNS and idiopathic Parkinson\u2019s disease","volume":"127","author":"Bandopadhyay","year":"2004","journal-title":"Brain"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1440-1789.2008.00955.x","article-title":"DJ-1 immunoreactivity in human brain astrocytes is dependent on infarct presence and infarct age","volume":"29","author":"Mullett","year":"2009","journal-title":"Neuropathology"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1097\/01.jnen.0000235121.98052.54","article-title":"LRRK2 expression in normal and pathologic human brain and in human cell lines","volume":"65","author":"Miklossy","year":"2006","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"105028","DOI":"10.1016\/j.nbd.2020.105028","article-title":"Microglia and astrocyte dysfunction in parkinson\u2019s disease","volume":"144","author":"Kam","year":"2020","journal-title":"Neurobiol. Dis."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"2744","DOI":"10.1038\/srep02744","article-title":"The intrinsic microglial molecular clock controls synaptic strength via the circadian expression of cathepsin S","volume":"3","author":"Hayashi","year":"2013","journal-title":"Sci. Rep."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3389\/fnmol.2016.00089","article-title":"Protective Microglia and Their Regulation in Parkinson\u2019s Disease","volume":"9","author":"Le","year":"2016","journal-title":"Front. Mol. Neurosci."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.tins.2010.12.001","article-title":"Astrocyte-neuron metabolic relationships: For better and for worse","volume":"34","author":"Allaman","year":"2011","journal-title":"Trends Neurosci."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s00401-009-0619-8","article-title":"Astrocytes: Biology and pathology","volume":"119","author":"Sofroniew","year":"2010","journal-title":"Acta Neuropathol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1177\/1073858409342593","article-title":"Functions of mature mammalian astrocytes: A current view","volume":"16","author":"Kimelberg","year":"2010","journal-title":"Neuroscientist"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/mds.23455","article-title":"Glia: Initiators and progressors of pathology in Parkinson\u2019s disease","volume":"26","author":"Halliday","year":"2011","journal-title":"Mov. Disord."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"12368","DOI":"10.1523\/JNEUROSCI.2102-14.2014","article-title":"Brain injection of alpha-synuclein induces multiple proteinopathies, gliosis, and a neuronal injury marker","volume":"34","author":"Sacino","year":"2014","journal-title":"J. Neurosci."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1046\/j.1365-2990.2001.00345.x","article-title":"Widespread occurrence of argyrophilic glial inclusions in Parkinson\u2019s disease","volume":"27","author":"Hishikawa","year":"2001","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s00401-007-0244-3","article-title":"Development of alpha-synuclein immunoreactive astrocytes in the forebrain parallels stages of intraneuronal pathology in sporadic Parkinson\u2019s disease","volume":"114","author":"Braak","year":"2007","journal-title":"Acta Neuropathol."},{"key":"ref_47","first-page":"90","article-title":"Microglial phenotypes and toll-like receptor 2 in the substantia nigra and hippocampus of incidental Lewy body disease cases and Parkinson\u2019s disease patients","volume":"2","author":"Doorn","year":"2014","journal-title":"Acta Neuropathol. Commun."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1007\/s00401-003-0766-2","article-title":"Distribution of major histocompatibility complex class II-positive microglia and cytokine profile of Parkinson\u2019s disease brains","volume":"106","author":"Imamura","year":"2003","journal-title":"Acta Neuropathol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1212\/WNL.38.8.1285","article-title":"Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson\u2019s and Alzheimer\u2019s disease brains","volume":"38","author":"McGeer","year":"1988","journal-title":"Neurology"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1038\/ng.485","article-title":"Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson\u2019s disease","volume":"41","author":"Satake","year":"2009","journal-title":"Nat. Genet."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"15002","DOI":"10.1038\/npjparkd.2015.2","article-title":"Common Genetic Variant Association with Altered HLA Expression, Synergy with Pyrethroid Exposure, and Risk for Parkinson\u2019s Disease: An Observational and Case-Control Study","volume":"1","author":"Kannarkat","year":"2015","journal-title":"npj Park. Dis."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1001\/archneur.63.6.833","article-title":"Clinical spectrum of homozygous and heterozygous PINK1 mutations in a large German family with Parkinson disease: Role of a single hit?","volume":"63","author":"Hedrich","year":"2006","journal-title":"Arch. Neurol."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Repici, M., and Giorgini, F. (2019). DJ-1 in Parkinson\u2019s Disease: Clinical Insights and Therapeutic Perspectives. J. Clin. Med., 8.","DOI":"10.3390\/jcm8091377"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/acn3.50990","article-title":"Nonmercaptalbumin as an oxidative stress marker in Parkinson\u2019s and PARK2 disease","volume":"7","author":"Ueno","year":"2020","journal-title":"Ann. Clin. Transl. Neur."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/s41531-021-00196-5","article-title":"A systematic review of associations between common SNCA variants and clinical heterogeneity in Parkinson\u2019s disease","volume":"7","author":"Pedersen","year":"2021","journal-title":"npj Park. Dis."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/s41582-019-0301-2","article-title":"LRRK2 in Parkinson disease: Challenges of clinical trials","volume":"16","author":"Tolosa","year":"2020","journal-title":"Nat. Rev. Neurol."},{"key":"ref_57","first-page":"48","article-title":"GBA-Associated Parkinson\u2019s Disease and Other Synucleinopathies","volume":"18","author":"Liong","year":"2018","journal-title":"Curr. Neurol. Neurosci."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1002\/mds.26243","article-title":"The role of ATP13A2 in Parkinson\u2019s disease: Clinical phenotypes and molecular mechanisms","volume":"30","author":"Park","year":"2015","journal-title":"Mov. Disord."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"e291","DOI":"10.1016\/j.neurobiolaging.2020.11.005","article-title":"Mutation analysis of TMEM family members for early-onset Parkinson\u2019s disease in Chinese population","volume":"101","author":"Li","year":"2021","journal-title":"Neurobiol. Aging"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.tins.2010.09.004","article-title":"Alpha-Synuclein and dopamine at the crossroads of Parkinson\u2019s disease","volume":"33","author":"Venda","year":"2010","journal-title":"Trends Neurosci."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"19666","DOI":"10.1073\/pnas.0807826105","article-title":"Structure of membrane-bound alpha-synuclein from site-directed spin labeling and computational refinement","volume":"105","author":"Jao","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"9595","DOI":"10.1074\/jbc.M411805200","article-title":"Structure and dynamics of micelle-bound human \u03b1-synuclein","volume":"280","author":"Ulmer","year":"2005","journal-title":"J. Biol. Chem."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0079-6123(10)83007-9","article-title":"Role of post-translational modifications in modulating the structure, function and toxicity of \u03b1-synuclein: Implications for Parkinson\u2019s disease pathogenesis and therapies","volume":"183","author":"Oueslati","year":"2010","journal-title":"Prog. Brain Res."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0014-5793(94)00395-5","article-title":"Identification of two distinct synucleins from human brain","volume":"345","author":"Jakes","year":"1994","journal-title":"FEBS Lett."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/nrn3406","article-title":"The many faces of alpha-synuclein: From structure and toxicity to therapeutic target","volume":"14","author":"Lashuel","year":"2013","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.bbrc.2007.04.108","article-title":"Expression of \u03b1-synuclein, a presynaptic protein implicated in Parkinson\u2019s disease, in erythropoietic lineage","volume":"358","author":"Nakai","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1097\/WNR.0b013e3282f03db4","article-title":"Localization of \u03b1-synuclein to mitochondria within midbrain of mice","volume":"18","author":"Li","year":"2007","journal-title":"NeuroReport"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.bbrc.2007.01.043","article-title":"Activation of the unfolded protein response in Parkinson\u2019s disease","volume":"354","author":"Hoozemans","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"48984","DOI":"10.1074\/jbc.M208194200","article-title":"Golgi fragmentation occurs in the cells with prefibrillar alpha-synuclein aggregates and precedes the formation of fibrillar inclusion","volume":"277","author":"Gosavi","year":"2002","journal-title":"J. Biol. Chem."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1523\/JNEUROSCI.3809-03.2004","article-title":"Clearance of alpha-synuclein oligomeric intermediates via the lysosomal degradation pathway","volume":"24","author":"Lee","year":"2004","journal-title":"J. Neurosci."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1523\/JNEUROSCI.08-08-02804.1988","article-title":"Synuclein: A neuron-specific protein localized to the nucleus and presynaptic nerve terminal","volume":"8","author":"Maroteaux","year":"1988","journal-title":"J. Neurosci."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1126\/science.1195227","article-title":"\u03b1-Synuclein promotes SNARE-complex assembly in vivo and in vitro","volume":"329","author":"Sharma","year":"2010","journal-title":"Science"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"11165","DOI":"10.1523\/JNEUROSCI.2559-04.2004","article-title":"Role of alpha-synuclein in presynaptic dopamine recruitment","volume":"24","author":"Yavich","year":"2004","journal-title":"J. Neurosci."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1749-6632.2010.05615.x","article-title":"Physiological functions of mitochondrial fusion","volume":"1201","author":"Chen","year":"2010","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/nature12985","article-title":"Mitochondrial form and function","volume":"505","author":"Friedman","year":"2014","journal-title":"Nature"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1093\/hmg\/ddr502","article-title":"The homocysteine-inducible endoplasmic reticulum (ER) stress protein Herp counteracts mutant alpha-synuclein-induced ER stress via the homeostatic regulation of ER-resident calcium release channel proteins","volume":"21","author":"Belal","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.ijdevneu.2008.05.006","article-title":"Golgi apparatus and neurodegenerative diseases","volume":"26","author":"Fan","year":"2008","journal-title":"Int. J. Dev. Neurosci."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s00401-006-0114-4","article-title":"Fragmentation of Golgi apparatus of nigral neurons with \u03b1-synuclein-positive inclusions in patients with Parkinson\u2019s disease","volume":"112","author":"Fujita","year":"2006","journal-title":"Acta Neuropathol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1212\/WNL.51.6.1757","article-title":"Mutation, sequence analysis, and association studies of alpha-synuclein in Parkinson\u2019s disease","volume":"51","author":"Parsian","year":"1998","journal-title":"Neurology"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"S63","DOI":"10.1002\/ana.410440710","article-title":"Autosomal dominant Parkinson\u2019s disease and alpha-Synuclein","volume":"44","author":"Polymeropoulos","year":"1998","journal-title":"Ann. Neurol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/S1474-4422(15)00246-X","article-title":"A seat at the table for people with Parkinson\u2019s disease","volume":"14","author":"Morgan","year":"2015","journal-title":"Lancet Neurol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1126\/science.1227157","article-title":"Pathological \u03b1-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice","volume":"338","author":"Luk","year":"2012","journal-title":"Science"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"17797","DOI":"10.1073\/pnas.1113260108","article-title":"A soluble alpha-synuclein construct forms a dynamic tetramer","volume":"108","author":"Wang","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"15345","DOI":"10.1074\/jbc.M111.318949","article-title":"Alpha-Synuclein in central nervous system and from erythrocytes, mammalian cells, and Escherichia coli exists predominantly as disordered monomer","volume":"287","author":"Fauvet","year":"2012","journal-title":"J. Biol. Chem."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/nature10324","article-title":"Alpha-Synuclein occurs physiologically as a helically folded tetramer that resists aggregation","volume":"477","author":"Bartels","year":"2011","journal-title":"Nature"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0896-6273(03)00024-2","article-title":"The formation of highly soluble oligomers of alpha-synuclein is regulated by fatty acids and enhanced in Parkinson\u2019s disease","volume":"37","author":"Sharon","year":"2003","journal-title":"Neuron"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"9427","DOI":"10.1021\/bi900539p","article-title":"Characterization of hydrophobic residue requirements for \u03b1-synuclein fibrillization","volume":"48","author":"Waxman","year":"2009","journal-title":"Biochemistry"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"8870","DOI":"10.1021\/bi034028+","article-title":"A peptide motif consisting of glycine, alanine, and valine is required for the fibrillization and cytotoxicity of human alpha-synuclein","volume":"42","author":"Du","year":"2003","journal-title":"Biochemistry"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"9843","DOI":"10.1074\/jbc.274.14.9843","article-title":"Both familial Parkinson\u2019s disease mutations accelerate alpha-synuclein aggregation","volume":"274","author":"Narhi","year":"1999","journal-title":"J. Biol. Chem."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1006\/jmbi.2001.5269","article-title":"Defective membrane interactions of familial Parkinson\u2019s disease mutant A30P alpha-synuclein","volume":"315","author":"Jo","year":"2002","journal-title":"J. Mol. Biol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.febslet.2004.09.038","article-title":"Mutation E46K increases phospholipid binding and assembly into filaments of human alpha-synuclein","volume":"576","author":"Choi","year":"2004","journal-title":"FEBS Lett."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1002\/mds.25421","article-title":"Alpha-synuclein p.H50Q.; a novel pathogenic mutation for Parkinson\u2019s disease","volume":"28","author":"Encarnacion","year":"2013","journal-title":"Mov. Disord."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/ana.23894","article-title":"G51D \u03b1-synuclein mutation causes a novel parkinsonian-pyramidal syndrome","volume":"73","author":"Lesage","year":"2013","journal-title":"Ann. Neurol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"2180.e1","DOI":"10.1016\/j.neurobiolaging.2014.03.024","article-title":"Novel alpha-synuclein mutation A53E associated with atypical multiple system atrophy and Parkinson\u2019s disease-type pathology","volume":"35","author":"Pasanen","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"248.e7","DOI":"10.1016\/j.neurobiolaging.2017.05.022","article-title":"Homozygous alpha-synuclein p.A53V in familial Parkinson\u2019s disease","volume":"57","author":"Yoshino","year":"2017","journal-title":"Neurobiol. Aging"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"3256","DOI":"10.1038\/emboj.2009.257","article-title":"Pre-fibrillar \u03b1-synuclein variants with impaired \u03b2-structure increase neurotoxicity in Parkinson\u2019s disease models","volume":"28","author":"Karpinar","year":"2009","journal-title":"EMBO J."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1096\/fj.01-0517fje","article-title":"Multiple phosphorylation of alpha-synuclein by protein tyrosine kinase Syk prevents eosin-induced aggregation","volume":"16","author":"Negro","year":"2002","journal-title":"FASEB J."},{"key":"ref_98","doi-asserted-by":"crossref","unstructured":"Mavroeidi, P., and Xilouri, M. (2021). Neurons and Glia Interplay in alpha-Synucleinopathies. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22094994"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"a024091","DOI":"10.1101\/cshperspect.a024091","article-title":"Cell Biology and Pathophysiology of alpha-Synuclein","volume":"8","author":"Burre","year":"2018","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3389\/fnmol.2014.00042","article-title":"Protein phosphorylation in neurodegeneration: Friend or foe?","volume":"7","author":"Tenreiro","year":"2014","journal-title":"Front. Mol. Neurosci."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/ncb748","article-title":"Alpha-Synuclein is phosphorylated in synucleinopathy lesions","volume":"4","author":"Fujiwara","year":"2002","journal-title":"Nat. Cell Biol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0304-3940(02)01258-2","article-title":"Phosphorylation of alpha-synuclein characteristic of synucleinopathy lesions is recapitulated in alpha-synuclein transgenic Drosophila","volume":"336","author":"Takahashi","year":"2003","journal-title":"Neurosci. Lett."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/nn1443","article-title":"Alpha-synuclein phosphorylation controls neurotoxicity and inclusion formation in a Drosophila model of Parkinson disease","volume":"8","author":"Chen","year":"2005","journal-title":"Nat. Neurosci."},{"key":"ref_104","doi-asserted-by":"crossref","unstructured":"Tenreiro, S., Reimao-Pinto, M.M., Antas, P., Rino, J., Wawrzycka, D., Macedo, D., Rosado-Ramos, R., Amen, T., Waiss, M., and Magalhaes, F. (2014). Phosphorylation modulates clearance of alpha-synuclein inclusions in a yeast model of Parkinson\u2019s disease. PLoS Genet., 10.","DOI":"10.1371\/journal.pgen.1004302"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"e2109617119","DOI":"10.1073\/pnas.2109617119","article-title":"Alpha-Synuclein phosphorylation at serine 129 occurs after initial protein deposition and inhibits seeded fibril formation and toxicity","volume":"119","author":"Ghanem","year":"2022","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1073\/pnas.0407146102","article-title":"Release of long-range tertiary interactions potentiates aggregation of natively unstructured alpha-synuclein","volume":"102","author":"Bertoncini","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"16895","DOI":"10.1074\/jbc.M800747200","article-title":"Phosphorylation at Ser-129 but not the phosphomimics S129E\/D inhibits the fibrillation of alpha-synuclein","volume":"283","author":"Paleologou","year":"2008","journal-title":"J. Biol. Chem."},{"key":"ref_108","first-page":"3257","article-title":"Tyrosine and serine phosphorylation of \u03b1-synuclein have opposing effects on neurotoxicity and soluble oligomer formation","volume":"119","author":"Chen","year":"2009","journal-title":"J. Clin. Investig."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"a024380","DOI":"10.1101\/cshperspect.a024380","article-title":"The Transcellular Propagation and Intracellular Trafficking of alpha-Synuclein","volume":"7","author":"Tofaris","year":"2017","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1006\/exnr.2002.8050","article-title":"Altered proteasomal function in sporadic Parkinson\u2019s disease","volume":"179","author":"McNaught","year":"2003","journal-title":"Exp. Neurol."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1016\/j.biocel.2008.01.017","article-title":"Assembly-dependent endocytosis and clearance of extracellular alpha-synuclein","volume":"40","author":"Lee","year":"2008","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"25009","DOI":"10.1074\/jbc.M300227200","article-title":"Alpha-Synuclein is degraded by both autophagy and the proteasome","volume":"278","author":"Webb","year":"2003","journal-title":"J. Biol. Chem."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0304-3940(00)01701-8","article-title":"Proteasomal function is impaired in substantia nigra in Parkinson\u2019s disease","volume":"297","author":"McNaught","year":"2001","journal-title":"Neurosci. Lett."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1126\/science.1060627","article-title":"Ubiquitination of a new form of alpha-synuclein by parkin from human brain: Implications for Parkinson\u2019s disease","volume":"293","author":"Shimura","year":"2001","journal-title":"Science"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"6838","DOI":"10.1523\/JNEUROSCI.5699-09.2010","article-title":"Cell-produced alpha-synuclein is secreted in a calcium-dependent manner by exosomes and impacts neuronal survival","volume":"30","author":"Emmanouilidou","year":"2010","journal-title":"J. Neurosci."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"3316","DOI":"10.1074\/jbc.M704809200","article-title":"Monoubiquitylation of alpha-synuclein by seven in absentia homolog (SIAH) promotes its aggregation in dopaminergic cells","volume":"283","author":"Rott","year":"2008","journal-title":"J. Biol. Chem."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1093\/hmg\/ddm363","article-title":"Ubiquitination of alpha-synuclein by Siah-1 promotes alpha-synuclein aggregation and apoptotic cell death","volume":"17","author":"Lee","year":"2008","journal-title":"Hum. Mol. Genet."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1097\/NEN.0b013e3186fc995","article-title":"Specificity and regulation of casein kinase-mediated phosphorylation of alpha-synuclein","volume":"67","author":"Waxman","year":"2008","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S0014-5793(01)03115-5","article-title":"Alpha-synuclein metabolism and aggregation is linked to ubiquitin-independent degradation by the proteasome","volume":"509","author":"Tofaris","year":"2001","journal-title":"FEBS Lett."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"40732","DOI":"10.1074\/jbc.M110.141952","article-title":"Phosphorylated \u03b1-synuclein at Ser-129 is targeted to the proteasome pathway in a ubiquitin-independent manner","volume":"285","author":"Machiya","year":"2010","journal-title":"J. Biol. Chem."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s40478-017-0452-6","article-title":"Mechanisms underlying extensive Ser129-phosphorylation in alpha-synuclein aggregates","volume":"5","author":"Arawaka","year":"2017","journal-title":"Acta Neuropathol. Commun."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/s41586-018-0104-4","article-title":"Cellular milieu imparts distinct pathological alpha-synuclein strains in alpha-synucleinopathies","volume":"557","author":"Peng","year":"2018","journal-title":"Nature"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.neurobiolaging.2008.07.008","article-title":"Cell-produced alpha-synuclein oligomers are targeted to, and impair, the 26S proteasome","volume":"31","author":"Emmanouilidou","year":"2010","journal-title":"Neurobiol. Aging"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1038\/s41467-018-03509-0","article-title":"A common mechanism of proteasome impairment by neurodegenerative disease-associated oligomers","volume":"9","author":"Thibaudeau","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"14508","DOI":"10.1523\/JNEUROSCI.1560-11.2011","article-title":"Distinct roles in vivo for the ubiquitin-proteasome system and the autophagy-lysosomal pathway in the degradation of alpha-synuclein","volume":"31","author":"Fan","year":"2011","journal-title":"J. Neurosci."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"8189","DOI":"10.1523\/JNEUROSCI.2218-08.2008","article-title":"Depletion of 26S proteasomes in mouse brain neurons causes neurodegeneration and Lewy-like inclusions resembling human pale bodies","volume":"28","author":"Bedford","year":"2008","journal-title":"J. Neurosci."},{"key":"ref_127","first-page":"1464","article-title":"Chaperone-mediated autophagy markers in, Parkinson disease brains","volume":"67","author":"Cooper","year":"2010","journal-title":"Arch. Neurol."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"23542","DOI":"10.1074\/jbc.M801992200","article-title":"Wild type \u03b1-synuclein is degraded by chaperone-mediated autophagy and macroautophagy in neuronal cells","volume":"283","author":"Vogiatzi","year":"2008","journal-title":"J. Biol. Chem."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"736","DOI":"10.2353\/ajpath.2009.080928","article-title":"Metabolic activity determines efficacy of macroautophagic clearance of pathological oligomeric \u03b1-synuclein","volume":"175","author":"Yu","year":"2009","journal-title":"Am. J. Pathol."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"15194","DOI":"10.1074\/jbc.M113.457408","article-title":"Lewy body-like alpha-synuclein aggregates resist degradation and impair macroautophagy","volume":"288","author":"Tanik","year":"2013","journal-title":"J. Biol. Chem."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"14241","DOI":"10.1074\/jbc.RA119.008733","article-title":"Autophagy activation promotes clearance of alpha-synuclein inclusions in fibril-seeded human neural cells","volume":"294","author":"Gao","year":"2019","journal-title":"J. Biol. Chem."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"754","DOI":"10.4161\/auto.19371","article-title":"Alpha-synuclein aggregation involves a bafilomycin A1-sensitive autophagy pathway","volume":"8","author":"Klucken","year":"2012","journal-title":"Autophagy"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1523\/JNEUROSCI.0089-14.2015","article-title":"A53T human alpha-synuclein overexpression in transgenic mice induces pervasive mitochondria macroautophagy defects preceding dopamine neuron degeneration","volume":"35","author":"Chen","year":"2015","journal-title":"J. Neurosci."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"6853","DOI":"10.1016\/S0021-9258(19)62694-3","article-title":"Regulation of catabolism of microinjected ribonuclease A. Identification of residues 7-11 as the essential pentapeptide","volume":"261","author":"Dice","year":"1986","journal-title":"J. Biol. Chem."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1038\/nature06639","article-title":"Autophagy fights disease through cellular self-digestion","volume":"451","author":"Mizushima","year":"2008","journal-title":"Nature"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1038\/nature05291","article-title":"The roles of intracellular protein-degradation pathways in neurodegeneration","volume":"443","author":"Rubinsztein","year":"2006","journal-title":"Nature"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.jmb.2006.08.062","article-title":"Heat shock protein 70 inhibits alpha-synuclein fibril formation via interactions with diverse intermediates","volume":"364","author":"Huang","year":"2006","journal-title":"J. Mol. Biol."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1126\/science.1101738","article-title":"Impaired degradation of mutant alpha-synuclein by chaperone-mediated autophagy","volume":"305","author":"Cuervo","year":"2004","journal-title":"Science"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1002\/mds.26477","article-title":"Autophagy and Alpha-Synuclein: Relevance to Parkinson\u2019s Disease and Related Synucleopathies","volume":"31","author":"Xilouri","year":"2016","journal-title":"Mov. Disord."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1002\/mds.26141","article-title":"Lysosomal-associated membrane protein 2 isoforms are differentially affected in early Parkinson\u2019s disease","volume":"30","author":"Murphy","year":"2015","journal-title":"Mov. Disord."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1080\/15548627.2016.1214777","article-title":"Impairment of chaperone-mediated autophagy induces dopaminergic neurodegeneration in rats","volume":"12","author":"Xilouri","year":"2016","journal-title":"Autophagy"},{"key":"ref_142","first-page":"777","article-title":"Dopamine-modified \u03b1-synuclein blocks chaperone-mediated autophagy","volume":"118","author":"Talloczy","year":"2008","journal-title":"J. Clin. Investig."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s40478-014-0182-y","article-title":"LAMP-2 deficiency leads to hippocampal dysfunction but normal clearance of neuronal substrates of chaperone-mediated autophagy in a mouse model for Danon disease","volume":"3","author":"Rothaug","year":"2015","journal-title":"Acta Neuropathol. Commun."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1126\/science.1675487","article-title":"Molecular biology of prion diseases","volume":"252","author":"Prusiner","year":"1991","journal-title":"Science"},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/nm1747","article-title":"Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson\u2019s disease","volume":"14","author":"Kordower","year":"2008","journal-title":"Nat. Med."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/nm1746","article-title":"Lewy bodies in grafted neurons in subjects with Parkinson\u2019s disease suggest host-to-graft disease propagation","volume":"14","author":"Li","year":"2008","journal-title":"Nat. Med."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1002\/ana.24066","article-title":"Lewy body extracts from, Parkinson disease brains trigger alpha-synuclein pathology and neurodegeneration in mice and monkeys","volume":"75","author":"Recasens","year":"2014","journal-title":"Ann. Neurol."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"20051","DOI":"10.1073\/pnas.0908005106","article-title":"Exogenous alpha-synuclein fibrils seed the formation of, L.ewy body-like intracellular inclusions in cultured cells","volume":"106","author":"Luk","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.nbd.2015.06.003","article-title":"Intrastriatal injection of pre-formed mouse alpha-synuclein fibrils into rats triggers alpha-synuclein pathology and bilateral nigrostriatal degeneration","volume":"82","author":"Paumier","year":"2015","journal-title":"Neurobiol. Dis."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.neuron.2011.08.033","article-title":"Exogenous alpha-synuclein fibrils induce Lewy body pathology leading to synaptic dysfunction and neuron death","volume":"72","author":"Luk","year":"2011","journal-title":"Neuron"},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0304-3940(00)01153-8","article-title":"Full length alpha-synuclein is present in cerebrospinal fluid from Parkinson\u2019s disease and normal subjects","volume":"287","author":"Borghi","year":"2000","journal-title":"Neurosci. Lett."},{"key":"ref_152","first-page":"1945","article-title":"Alpha-synuclein implicated in Parkinson\u2019s disease is present in extracellular biological fluids, including human plasma","volume":"17","author":"Salem","year":"2003","journal-title":"FASEB J."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"6016","DOI":"10.1523\/JNEUROSCI.0692-05.2005","article-title":"Intravesicular localization and exocytosis of alpha-synuclein and its aggregates","volume":"25","author":"Lee","year":"2005","journal-title":"J. Neurosci."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"25216","DOI":"10.1074\/jbc.M503341200","article-title":"Proteolytic cleavage of extracellular secreted {alpha}-synuclein via matrix metalloproteinases","volume":"280","author":"Sung","year":"2005","journal-title":"J. Biol. Chem."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1750-1326-7-42","article-title":"Exosomal cell-to-cell transmission of alpha synuclein oligomers","volume":"7","author":"Danzer","year":"2012","journal-title":"Mol. Neurodegener."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.nbd.2011.01.029","article-title":"Lysosomal dysfunction increases exosome-mediated alpha-synuclein release and transmission","volume":"42","author":"Seow","year":"2011","journal-title":"Neurobiol. Dis."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1007\/s00401-014-1314-y","article-title":"Plasma exosomal alpha-synuclein is likely CNS-derived and increased in Parkinson\u2019s disease","volume":"128","author":"Shi","year":"2014","journal-title":"Acta Neuropathol."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1111\/j.1471-4159.2010.06695.x","article-title":"Non-classical exocytosis of alpha-synuclein is sensitive to folding states and promoted under stress conditions","volume":"113","author":"Jang","year":"2010","journal-title":"J. Neurochem."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"17313","DOI":"10.1074\/jbc.M112.401174","article-title":"Tubulin polymerization-promoting protein (TPPP\/p25alpha) promotes unconventional secretion of alpha-synuclein through exophagy by impairing autophagosome-lysosome fusion","volume":"288","author":"Ejlerskov","year":"2013","journal-title":"J. Biol. Chem."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1523\/JNEUROSCI.6202-08.2009","article-title":"Rab11a and HSP90 regulate recycling of extracellular alpha-synuclein","volume":"29","author":"Liu","year":"2009","journal-title":"J. Neurosci."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1093\/brain\/awt037","article-title":"Prion-like spreading of pathological alpha-synuclein in brain","volume":"136","author":"Nonaka","year":"2013","journal-title":"Brain"},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1038\/nprot.2014.143","article-title":"Addition of exogenous alpha-synuclein preformed fibrils to primary neuronal cultures to seed recruitment of endogenous alpha-synuclein to Lewy body and Lewy neurite-like aggregates","volume":"9","author":"Luk","year":"2014","journal-title":"Nat. Protoc."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.bbrc.2008.05.045","article-title":"Clearance and deposition of extracellular alpha-synuclein aggregates in microglia","volume":"372","author":"Lee","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"13010","DOI":"10.1073\/pnas.0903691106","article-title":"Inclusion formation and neuronal cell death through neuron-to-neuron transmission of alpha-synuclein","volume":"106","author":"Desplats","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1172\/JCI43366","article-title":"Alpha-Synuclein propagates from mouse brain to grafted dopaminergic neurons and seeds aggregation in cultured human cells","volume":"121","author":"Hansen","year":"2011","journal-title":"J. Clin. Investig."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1750-1326-7-38","article-title":"Suppression of dynamin GTPase decreases alpha-synuclein uptake by neuronal and oligodendroglial cells: A potent therapeutic target for synucleinopathy","volume":"7","author":"Konno","year":"2012","journal-title":"Mol. Neurodegener."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/j.celrep.2017.01.005","article-title":"Auxilin Underlies Progressive Locomotor Deficits and Dopaminergic Neuron Loss in a Drosophila Model of Parkinson\u2019s Disease","volume":"18","author":"Song","year":"2017","journal-title":"Cell Rep."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"aah3374","DOI":"10.1126\/science.aah3374","article-title":"Pathological alpha-synuclein transmission initiated by binding lymphocyte-activation gene 3","volume":"353","author":"Mao","year":"2016","journal-title":"Science"},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.15252\/embj.201591397","article-title":"Alpha-synuclein assemblies sequester neuronal alpha3-Na+\/K+-ATPase and impair Na+ gradient","volume":"34","author":"Shrivastava","year":"2015","journal-title":"EMBO J."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s00401-019-02007-x","article-title":"Binding of alpha-synuclein oligomers to Cx32 facilitates protein uptake and transfer in neurons and oligodendrocytes","volume":"138","author":"Reyes","year":"2019","journal-title":"Acta Neuropathol."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"E3138","DOI":"10.1073\/pnas.1301440110","article-title":"Heparan sulfate proteoglycans mediate internalization and propagation of specific proteopathic seeds","volume":"110","author":"Holmes","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1146\/annurev.biochem.78.081307.110540","article-title":"Mechanisms of endocytosis","volume":"78","author":"Doherty","year":"2009","journal-title":"Annu. Rev. Biochem."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1038\/icb.2011.20","article-title":"Macropinocytosis: An endocytic pathway for internalising large gulps","volume":"89","author":"Lim","year":"2011","journal-title":"Immunol. Cell Biol."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1042\/EBC20210026","article-title":"Membrane lipid raft homeostasis is directly linked to neurodegeneration","volume":"65","author":"Moll","year":"2021","journal-title":"Essays Biochem."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"6715","DOI":"10.1523\/JNEUROSCI.1594-04.2004","article-title":"Lipid rafts mediate the synaptic localization of alpha-synuclein","volume":"24","author":"Fortin","year":"2004","journal-title":"J. Neurosci."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"31664","DOI":"10.1074\/jbc.M504894200","article-title":"A combinatorial code for the interaction of alpha-synuclein with membranes","volume":"280","author":"Kubo","year":"2005","journal-title":"J. Biol. Chem."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"3614","DOI":"10.1021\/pr0701512","article-title":"Identification of proteins involved in microglial endocytosis of alpha-synuclein","volume":"6","author":"Liu","year":"2007","journal-title":"J. Proteome Res."},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s00401-015-1504-2","article-title":"Age-dependent defects of alpha-synuclein oligomer uptake in microglia and monocytes","volume":"131","author":"Bliederhaeuser","year":"2016","journal-title":"Acta Neuropathol."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/978-981-13-9913-8_13","article-title":"Microglia in Parkinson\u2019s Disease","volume":"Volume 1175","author":"Verkhratsky","year":"2019","journal-title":"Neuroglia in Neurodegenerative Diseases"},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1096\/fj.04-2751com","article-title":"Aggregated alpha-synuclein activates microglia: A process leading to disease progression in Parkinson\u2019s disease","volume":"19","author":"Zhang","year":"2005","journal-title":"FASEB J."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1111\/j.1471-4159.2009.06150.x","article-title":"On the mechanism of internalization of alpha-synuclein into microglia: Roles of ganglioside, G.M1 and lipid raft","volume":"110","author":"Park","year":"2009","journal-title":"J. Neurochem."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1111\/jnc.14222","article-title":"DJ-1 deficiency impairs autophagy and reduces alpha-synuclein phagocytosis by microglia","volume":"143","author":"Nash","year":"2017","journal-title":"J. Neurochem."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1038\/ncomms2534","article-title":"Neuron-released oligomeric alpha-synuclein is an endogenous agonist of TLR2 for paracrine activation of microglia","volume":"4","author":"Kim","year":"2013","journal-title":"Nat. Commun."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/glia.22437","article-title":"Toll-like receptor 4 is required for alpha-synuclein dependent activation of microglia and astroglia","volume":"61","author":"Fellner","year":"2013","journal-title":"Glia"},{"key":"ref_185","first-page":"E1926","article-title":"Alpha-Synuclein, a chemoattractant, directs microglial migration via H2O2-dependent Lyn phosphorylation","volume":"112","author":"Wang","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.redox.2017.11.010","article-title":"Integrin CD11b mediates alpha-synuclein-induced activation of NADPH oxidase through a Rho-dependent pathway","volume":"14","author":"Hou","year":"2018","journal-title":"Redox Biol."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1186\/s12974-020-01823-3","article-title":"Integrin CD11b mediates locus coeruleus noradrenergic neurodegeneration in a mouse Parkinson\u2019s disease model","volume":"17","author":"Hou","year":"2020","journal-title":"J. Neuroinflamm."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1111\/j.1471-4159.2009.06075.x","article-title":"Alpha-synuclein induces migration of BV-2 microglial cells by up-regulation of CD44 and MT1-MMP","volume":"109","author":"Kim","year":"2009","journal-title":"J. Neurochem."},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"615","DOI":"10.4049\/jimmunol.0903480","article-title":"Alpha-synuclein activates microglia by inducing the expressions of matrix metalloproteinases and the subsequent activation of protease-activated receptor-1","volume":"185","author":"Lee","year":"2010","journal-title":"J. Immunol."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1186\/1742-2094-9-259","article-title":"The gamma chain subunit of Fc receptors is required for alpha-synuclein-induced pro-inflammatory signaling in microglia","volume":"9","author":"Cao","year":"2012","journal-title":"J. Neuroinflamm."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1002\/glia.20532","article-title":"Microglial PHOX and Mac-1 are essential to the enhanced dopaminergic neurodegeneration elicited by A30P and A53T mutant alpha-synuclein","volume":"55","author":"Zhang","year":"2007","journal-title":"Glia"},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1016\/j.neurobiolaging.2015.03.015","article-title":"P2X7 receptor is critical in alpha-synuclein\u2014Mediated microglial NADPH oxidase activation","volume":"36","author":"Jiang","year":"2015","journal-title":"Neurobiol. Aging"},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1084\/jem.20182191","article-title":"Fyn kinase regulates misfolded alpha-synuclein uptake and NLRP3 inflammasome activation in microglia","volume":"216","author":"Panicker","year":"2019","journal-title":"J. Exp. Med."},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/j.1471-4159.2006.04315.x","article-title":"Ion channel blockade attenuates aggregated alpha synuclein induction of microglial reactive oxygen species: Relevance for the pathogenesis of Parkinson\u2019s disease","volume":"100","author":"Thomas","year":"2007","journal-title":"J. Neurochem."},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1038\/s41467-020-15119-w","article-title":"Microglia clear neuron-released alpha-synuclein via selective autophagy and prevent neurodegeneration","volume":"11","author":"Choi","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"jcs226241","DOI":"10.1242\/jcs.226241","article-title":"Alpha-synuclein fibrils recruit TBK1 and OPTN to lysosomal damage sites and induce autophagy in microglial cells","volume":"131","author":"Bussi","year":"2018","journal-title":"J. Cell Sci."},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1093\/brain\/awaa090","article-title":"Microglial exosomes facilitate alpha-synuclein transmission in Parkinson\u2019s disease","volume":"143","author":"Guo","year":"2020","journal-title":"Brain"},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.neulet.2013.06.009","article-title":"Exosomes of BV-2 cells induced by alpha-synuclein: Important mediator of neurodegeneration in PD","volume":"548","author":"Chang","year":"2013","journal-title":"Neurosci. Lett."},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"9262","DOI":"10.1074\/jbc.M109.081125","article-title":"Direct transfer of alpha-synuclein from neuron to astroglia causes inflammatory responses in synucleinopathies","volume":"285","author":"Lee","year":"2010","journal-title":"J. Biol. Chem."},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.nbd.2017.04.011","article-title":"In vitro alpha-synuclein neurotoxicity and spreading among neurons and astrocytes using Lewy body extracts from Parkinson disease brains","volume":"103","author":"Cavaliere","year":"2017","journal-title":"Neurobiol. Dis."},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1007\/s00401-017-1746-2","article-title":"Alpha-Synuclein transfer between neurons and astrocytes indicates that astrocytes play a role in degradation rather than in spreading","volume":"134","author":"Loria","year":"2017","journal-title":"Acta Neuropathol."},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.stemcr.2018.12.011","article-title":"Patient-specific iPSC-derived astrocytes contribute to non-cell-autonomous neurodegeneration in Parkinson\u2019s disease","volume":"12","author":"Carola","year":"2019","journal-title":"Stem Cell Rep."},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1007\/s10571-019-00696-2","article-title":"Enhancing the Astrocytic Clearance of Extracellular alpha-Synuclein Aggregates by Ginkgolides Attenuates Neural Cell Injury","volume":"39","author":"Hua","year":"2019","journal-title":"Cell. Mol. Neurobiol."},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s13024-017-0182-z","article-title":"Intrastriatal injection of alpha-synuclein can lead to widespread synucleinopathy independent of neuroanatomic connectivity","volume":"12","author":"Sorrentino","year":"2017","journal-title":"Mol. Neurodegener."},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.nbd.2018.09.005","article-title":"Motor neuron loss and neuroinflammation in a model of alpha-synuclein-induced neurodegeneration","volume":"120","author":"Sorrentino","year":"2018","journal-title":"Neurobiol. Dis."},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"17775","DOI":"10.1523\/JNEUROSCI.3049-12.2012","article-title":"Astrocyte-specific overexpression of Nrf2 delays motor pathology and synuclein aggregation throughout the CNS in the alpha-synuclein mutant (A53T) mouse model","volume":"32","author":"Gan","year":"2012","journal-title":"J. Neurosci."},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/jnr.24092","article-title":"Overexpression of alpha-synuclein in an astrocyte cell line promotes autophagy inhibition and apoptosis","volume":"96","author":"Erustes","year":"2018","journal-title":"J. Neurosci. Res."},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1007\/BF00427222","article-title":"Lewy bodies in Parkinson\u2019s disease are recognized by antibodies to complement proteins","volume":"84","author":"Yamada","year":"1992","journal-title":"Acta Neuropathol."},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/PL00007400","article-title":"NACP\/alpha-synuclein-positive filamentous inclusions in astrocytes and oligodendrocytes of Parkinson\u2019s disease brains","volume":"99","author":"Wakabayashi","year":"2000","journal-title":"Acta Neuropathol."},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1007\/s00702-007-0790-9","article-title":"Damage to oligodendrocytes in the striatum after MPTP neurotoxicity in mice","volume":"114","author":"Takagi","year":"2007","journal-title":"J. Neural Transm."},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1126\/science.6823561","article-title":"Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis","volume":"219","author":"Langston","year":"1983","journal-title":"Science"},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1002\/1531-8249(199910)46:4<598::AID-ANA7>3.0.CO;2-F","article-title":"Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure","volume":"46","author":"Langston","year":"1999","journal-title":"Ann. Neurol."},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1602\/neurorx.2.3.484","article-title":"Toxin-induced models of Parkinson\u2019s disease","volume":"2","author":"Bove","year":"2005","journal-title":"NeuroRx"},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"337","DOI":"10.5607\/en.2014.23.4.337","article-title":"Exploring myelin dysfunction in multiple system atrophy","volume":"23","author":"Wong","year":"2014","journal-title":"Exp. Neurobiol."},{"key":"ref_215","doi-asserted-by":"crossref","unstructured":"Kisos, H., Pukass, K., Ben-Hur, T., Richter-Landsberg, C., and Sharon, R. (2012). Increased neuronal alpha-synuclein pathology associates with its accumulation in oligodendrocytes in mice modeling alpha-synucleinopathies. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0046817"},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s12031-013-0154-x","article-title":"Oxidative stress promotes uptake, accumulation, and oligomerization of extracellular alpha-synuclein in oligodendrocytes","volume":"52","author":"Pukass","year":"2014","journal-title":"J. Mol. Neurosci."},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1002\/glia.22611","article-title":"Alpha-synuclein transfers from neurons to oligodendrocytes","volume":"62","author":"Reyes","year":"2014","journal-title":"Glia"},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s00418-008-0412-0","article-title":"The art of cellular communication: Tunneling nanotubes bridge the divide","volume":"129","author":"Gurke","year":"2008","journal-title":"Histochem. Cell Biol."},{"key":"ref_219","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1126\/science.1093133","article-title":"Nanotubular highways for intercellular organelle transport","volume":"303","author":"Rustom","year":"2004","journal-title":"Science"},{"key":"ref_220","doi-asserted-by":"crossref","first-page":"3695","DOI":"10.1242\/jcs.02507","article-title":"Hydrogen peroxide alters membrane and cytoskeleton properties and increases intercellular connections in astrocytes","volume":"118","author":"Zhu","year":"2005","journal-title":"J. Cell Sci."},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"e438","DOI":"10.1038\/cddis.2012.177","article-title":"Tunneling-nanotube direction determination in neurons and astrocytes","volume":"3","author":"Sun","year":"2012","journal-title":"Cell Death Dis."},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.15252\/embj.201593411","article-title":"haumont, F.; Pieri, L.; Olivo-Marin, J.C.; Melki, R.; Zurzolo, C. Tunneling nanotubes spread fibrillar alpha-synuclein by intercellular trafficking of lysosomes","volume":"35","author":"Abounit","year":"2016","journal-title":"EMBO J."},{"key":"ref_223","doi-asserted-by":"crossref","first-page":"42984","DOI":"10.1038\/srep42984","article-title":"Alpha-synuclein transfer through tunneling nanotubes occurs in, S.H-SY5Y cells and primary brain pericytes from Parkinson\u2019s disease patients","volume":"7","author":"Dieriks","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_224","doi-asserted-by":"crossref","first-page":"11835","DOI":"10.1523\/JNEUROSCI.0983-17.2017","article-title":"Human Astrocytes Transfer Aggregated Alpha-Synuclein via Tunneling Nanotubes","volume":"37","author":"Rostami","year":"2017","journal-title":"J. Neurosci."},{"key":"ref_225","doi-asserted-by":"crossref","first-page":"5089","DOI":"10.1016\/j.cell.2021.09.007","article-title":"Microglia jointly degrade fibrillar alpha-synuclein cargo by distribution through tunneling nanotubes","volume":"184","author":"Scheiblich","year":"2021","journal-title":"Cell"},{"key":"ref_226","doi-asserted-by":"crossref","unstructured":"Sanchez-Guajardo, V., Febbraro, F., Kirik, D., and Romero-Ramos, M. (2010). Microglia acquire distinct activation profiles depending on the degree of alpha-synuclein neuropathology in a rAAV based model of Parkinson\u2019s disease. PLoS ONE, 5.","DOI":"10.1371\/journal.pone.0008784"},{"key":"ref_227","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.neuroscience.2012.02.004","article-title":"Long-term polarization of microglia upon alpha-synuclein overexpression in nonhuman primates","volume":"208","author":"Barkholt","year":"2012","journal-title":"Neuroscience"},{"key":"ref_228","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.expneurol.2012.06.025","article-title":"Regionally-specific microglial activation in young mice over-expressing human wildtype alpha-synuclein","volume":"237","author":"Watson","year":"2012","journal-title":"Exp. Neurol."},{"key":"ref_229","doi-asserted-by":"crossref","unstructured":"Hoenen, C., Gustin, A., Birck, C., Kirchmeyer, M., Beaume, N., Felten, P., Grandbarbe, L., Heuschling, P., and Heurtaux, T. (2016). Alpha-Synuclein Proteins Promote Pro-Inflammatory Cascades in Microglia: Stronger Effects of the A53T Mutant. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0162717"},{"key":"ref_230","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1756-6606-3-12","article-title":"Astrocytic expression of Parkinson\u2019s disease-related A53T alpha-synuclein causes neurodegeneration in mice","volume":"3","author":"Gu","year":"2010","journal-title":"Mol. Brain"},{"key":"ref_231","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1007\/s12640-009-9053-x","article-title":"Mutant alpha-synuclein overexpression mediates early proinflammatory activity","volume":"16","author":"Su","year":"2009","journal-title":"Neurotox. Res."},{"key":"ref_232","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0304-3940(03)00172-1","article-title":"Selective microglial activation in the rat rotenone model of Parkinson\u2019s disease","volume":"341","author":"Sherer","year":"2003","journal-title":"Neurosci. Lett."},{"key":"ref_233","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/ana.20338","article-title":"Microglial activation and dopamine terminal loss in early Parkinson\u2019s disease","volume":"57","author":"Ouchi","year":"2005","journal-title":"Ann. Neurol."},{"key":"ref_234","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.nbd.2005.08.002","article-title":"In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson\u2019s disease","volume":"21","author":"Gerhard","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"ref_235","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13024-019-0335-3","article-title":"Microglia affect alpha-synuclein cell-to-cell transfer in a mouse model of Parkinson\u2019s disease","volume":"14","author":"George","year":"2019","journal-title":"Mol. Neurodegener."},{"key":"ref_236","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1097\/NEN.0b013e31818e5e99","article-title":"Targeted overexpression of human alpha-synuclein triggers microglial activation and an adaptive immune response in a mouse model of Parkinson disease","volume":"67","author":"Theodore","year":"2008","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"ref_237","doi-asserted-by":"crossref","first-page":"3365","DOI":"10.1523\/JNEUROSCI.5427-08.2009","article-title":"Dynamic changes in presynaptic and axonal transport proteins combined with striatal neuroinflammation precede dopaminergic neuronal loss in a rat model of AAV alpha-synucleinopathy","volume":"29","author":"Chung","year":"2009","journal-title":"J. Neurosci."},{"key":"ref_238","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s11064-005-9233-x","article-title":"Reactive macrophages increase oxidative stress and alpha-synuclein nitration during death of dopaminergic neuronal cells in co-culture: Relevance to Parkinson\u2019s disease","volume":"31","author":"Shavali","year":"2006","journal-title":"Neurochem. Res."},{"key":"ref_239","doi-asserted-by":"crossref","first-page":"7687","DOI":"10.1523\/JNEUROSCI.0143-07.2008","article-title":"Neuroinflammation and oxidation\/nitration of alpha-synuclein linked to dopaminergic neurodegeneration","volume":"28","author":"Gao","year":"2008","journal-title":"J. Neurosci."},{"key":"ref_240","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0896-6273(02)00794-8","article-title":"Inflammation in neurodegenerative disease\u2014A double-edged sword","volume":"35","author":"Mucke","year":"2002","journal-title":"Neuron"},{"key":"ref_241","doi-asserted-by":"crossref","first-page":"514","DOI":"10.3389\/fncel.2019.00514","article-title":"Pharmacological Targeting of Microglial Activation: New Therapeutic Approach","volume":"13","author":"Liu","year":"2019","journal-title":"Front. Cell. Neurosci."},{"key":"ref_242","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/nan.12011","article-title":"Review: Activation patterns of microglia and their identification in the human brain","volume":"39","author":"Boche","year":"2013","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"ref_243","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.nbd.2014.08.011","article-title":"Dynamic changes in pro- and anti-inflammatory cytokines in microglia after PPAR-gamma agonist neuroprotective treatment in the MPTPp mouse model of progressive Parkinson\u2019s disease","volume":"71","author":"Pisanu","year":"2014","journal-title":"Neurobiol. Dis."},{"key":"ref_244","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.exger.2018.07.010","article-title":"Aging modulates microglia phenotypes in neuroinflammation of MPTP-PD mice","volume":"111","author":"Yao","year":"2018","journal-title":"Exp. Gerontol."},{"key":"ref_245","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s40478-017-0494-9","article-title":"Alpha-Synuclein fibrils recruit peripheral immune cells in the rat brain prior to neurodegeneration","volume":"5","author":"Harms","year":"2017","journal-title":"Acta Neuropathol. Commun."},{"key":"ref_246","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1177\/039463200902200405","article-title":"Suppression of MAP kinases inhibits microglial activation and attenuates neuronal cell death induced by alpha-synuclein protofibrils","volume":"22","author":"Wilms","year":"2009","journal-title":"Int. J. Immunopathol. Pharmacol."},{"key":"ref_247","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.neurobiolaging.2006.11.013","article-title":"Alpha-synuclein activates stress signaling protein kinases in, T.HP-1 cells and microglia","volume":"29","author":"Klegeris","year":"2008","journal-title":"Neurobiol. Aging"},{"key":"ref_248","doi-asserted-by":"crossref","first-page":"ra45","DOI":"10.1126\/scisignal.2005965","article-title":"Activation of MyD88-dependent TLR1\/2 signaling by misfolded alpha-synuclein, a protein linked to neurodegenerative disorders","volume":"8","author":"Daniele","year":"2015","journal-title":"Sci. Signal."},{"key":"ref_249","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1742-2094-4-2","article-title":"Prostaglandin E2 receptor subtype 2 (EP2) regulates microglial activation and associated neurotoxicity induced by aggregated alpha-synuclein","volume":"4","author":"Jin","year":"2007","journal-title":"J. Neuroinflamm."},{"key":"ref_250","doi-asserted-by":"crossref","unstructured":"Codolo, G., Plotegher, N., Pozzobon, T., Brucale, M., Tessari, I., Bubacco, L., and de Bernard, M. (2013). Triggering of inflammasome by aggregated alpha-synuclein, an inflammatory response in synucleinopathies. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0055375"},{"key":"ref_251","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s13024-016-0094-3","article-title":"MicroRNA-7 targets Nod-like receptor protein 3 inflammasome to modulate neuroinflammation in the pathogenesis of Parkinson\u2019s disease","volume":"11","author":"Zhou","year":"2016","journal-title":"Mol. Neurodegener."},{"key":"ref_252","doi-asserted-by":"crossref","first-page":"719807","DOI":"10.3389\/fimmu.2021.719807","article-title":"Targeting Microglial alpha-Synuclein\/TLRs\/NF-kappaB\/NLRP3 Inflammasome Axis in Parkinson\u2019s Disease","volume":"12","author":"Li","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_253","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1523\/JNEUROSCI.5601-11.2012","article-title":"LRRK2 inhibition attenuates microglial inflammatory responses","volume":"32","author":"Moehle","year":"2012","journal-title":"J. Neurosci."},{"key":"ref_254","doi-asserted-by":"crossref","unstructured":"Kim, B., Yang, M., Choi, D., Kim, J.H., Kim, H.S., Seol, W., Choi, S., Jou, I., Kim, E.Y., and Joe, E.H. (2012). Impaired inflammatory responses in murine Lrrk2-knockdown brain microglia. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0034693"},{"key":"ref_255","doi-asserted-by":"crossref","first-page":"9289","DOI":"10.1073\/pnas.1403215111","article-title":"Abrogation of alpha-synuclein-mediated dopaminergic neurodegeneration in, L.RRK2-deficient rats","volume":"111","author":"Daher","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_256","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1007\/s11481-012-9401-0","article-title":"Microglial activation and antioxidant responses induced by the Parkinson\u2019s disease protein alpha-synuclein","volume":"8","author":"Beraud","year":"2013","journal-title":"J. Neuroimmune. Pharmacol."},{"key":"ref_257","doi-asserted-by":"crossref","first-page":"3173","DOI":"10.1093\/hmg\/dds143","article-title":"Alpha-Synuclein expression and Nrf2 deficiency cooperate to aggravate protein aggregation, neuronal death and inflammation in early-stage Parkinson\u2019s disease","volume":"21","author":"Ulusoy","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"ref_258","doi-asserted-by":"crossref","first-page":"211","DOI":"10.3389\/fncel.2014.00211","article-title":"Astrocytic modulation of blood brain barrier: Perspectives on Parkinson\u2019s disease","volume":"8","author":"Cabezas","year":"2014","journal-title":"Front. Cell. Neurosci."},{"key":"ref_259","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/jcbfm.2015.32","article-title":"Striatal blood-brain barrier permeability in Parkinson\u2019s disease","volume":"35","author":"Gray","year":"2015","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"ref_260","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1097\/NEN.0b013e3181b66f1b","article-title":"Degeneration in different parkinsonian syndromes relates to astrocyte type and astrocyte protein expression","volume":"68","author":"Song","year":"2009","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"ref_261","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.expneurol.2005.10.034","article-title":"Role of ICAM-1 in persisting inflammation in Parkinson disease and MPTP monkeys","volume":"197","author":"Miklossy","year":"2006","journal-title":"Exp. Neurol."},{"key":"ref_262","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.neures.2008.09.001","article-title":"Differential astroglial activation in 6-hydroxydopamine models of Parkinson\u2019s disease","volume":"62","author":"Henning","year":"2008","journal-title":"Neurosci. Res."},{"key":"ref_263","doi-asserted-by":"crossref","unstructured":"Miyazaki, I., and Asanuma, M. (2020). Neuron-Astrocyte Interactions in Parkinson\u2019s Disease. Cells, 9.","DOI":"10.3390\/cells9122623"},{"key":"ref_264","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nature21029","article-title":"Neurotoxic reactive astrocytes are induced by activated microglia","volume":"541","author":"Liddelow","year":"2017","journal-title":"Nature"},{"key":"ref_265","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1096\/fj.06-6183com","article-title":"Alpha-synuclein and its disease-causing mutants induce ICAM-1 and IL-6 in human astrocytes and astrocytoma cells","volume":"20","author":"Klegeris","year":"2006","journal-title":"FASEB J."},{"key":"ref_266","doi-asserted-by":"crossref","first-page":"3153","DOI":"10.1042\/BCJ20180297","article-title":"Impact of monomeric, oligomeric and fibrillar alpha-synuclein on astrocyte reactivity and toxicity to neurons","volume":"475","author":"Chavarria","year":"2018","journal-title":"Biochem. J."},{"key":"ref_267","doi-asserted-by":"crossref","unstructured":"Rannikko, E.H., Weber, S.S., and Kahle, P.J. (2015). Exogenous alpha-synuclein induces toll-like receptor 4 dependent inflammatory responses in astrocytes. BMC Neurosci., 16.","DOI":"10.1186\/s12868-015-0192-0"},{"key":"ref_268","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1002\/glia.23631","article-title":"Connexin 43 hemichannels and pannexin-1 channels contribute to the alpha-synuclein-induced dysfunction and death of astrocytes","volume":"67","author":"Diaz","year":"2019","journal-title":"Glia"},{"key":"ref_269","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.neulet.2009.11.034","article-title":"GFAP reactivity, apolipoprotein, E. redistribution and cholesterol reduction in human astrocytes treated with alpha-synuclein","volume":"469","author":"Koob","year":"2010","journal-title":"Neurosci. Lett."},{"key":"ref_270","first-page":"322","article-title":"Alphasynuclein induces apoptosis of astrocytes by causing dysfunction of the endoplasmic reticulumGolgi compartment","volume":"18","author":"Liu","year":"2018","journal-title":"Mol. Med. Rep."},{"key":"ref_271","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.1073\/pnas.0813361106","article-title":"Nrf2-mediated neuroprotection in the MPTP mouse model of Parkinson\u2019s disease: Critical role for the astrocyte","volume":"106","author":"Chen","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_272","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.neuro.2012.01.015","article-title":"Activation of the Nrf2-ARE pathway by siRNA knockdown of Keap1 reduces oxidative stress and provides partial protection from MPTP-mediated neurotoxicity","volume":"33","author":"Williamson","year":"2012","journal-title":"Neurotoxicology"},{"key":"ref_273","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.immuni.2017.06.006","article-title":"Reactive Astrocytes: Production, Function, and Therapeutic Potential","volume":"46","author":"Liddelow","year":"2017","journal-title":"Immunity"},{"key":"ref_274","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/s41591-018-0051-5","article-title":"Block of A1 astrocyte conversion by microglia is neuroprotective in models of Parkinson\u2019s disease","volume":"24","author":"Yun","year":"2018","journal-title":"Nat. Med."},{"key":"ref_275","doi-asserted-by":"crossref","first-page":"2878","DOI":"10.1523\/JNEUROSCI.2534-16.2017","article-title":"Astrocytic Orosomucoid-2 Modulates Microglial Activation and Neuroinflammation","volume":"37","author":"Jo","year":"2017","journal-title":"J. Neurosci."},{"key":"ref_276","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.taap.2004.08.007","article-title":"Microglia is activated by astrocytes in trimethyltin intoxication","volume":"204","author":"Rohl","year":"2005","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"ref_277","doi-asserted-by":"crossref","unstructured":"Riederer, P., Reichmann, H., Youdim, M.B.H., and Gerlach, M. (2006). Role of cytokines in inflammatory process in Parkinson\u2019s disease. Parkinson\u2019s Disease and Related Disorders, Springer. Journal of Neural Transmission. Supplementa.","DOI":"10.1007\/978-3-211-45295-0"},{"key":"ref_278","doi-asserted-by":"crossref","first-page":"42136","DOI":"10.1074\/jbc.M200862200","article-title":"The HIV-1 Nef protein and phagocyte NADPH oxidase activation","volume":"277","author":"Vilhardt","year":"2002","journal-title":"J. Biol. Chem."},{"key":"ref_279","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1007\/s10571-006-9061-9","article-title":"Cellular and molecular mechanisms of Parkinson\u2019s disease: Neurotoxins, causative genes, and inflammatory cytokines","volume":"26","author":"Nagatsu","year":"2006","journal-title":"Cell. Mol. Neurobiol."},{"key":"ref_280","doi-asserted-by":"crossref","first-page":"882316","DOI":"10.3389\/fnins.2022.882316","article-title":"Astrocytes in Neurodegeneration: Inspiration From Genetics","volume":"16","author":"Huang","year":"2022","journal-title":"Front. Neurosci."},{"key":"ref_281","doi-asserted-by":"crossref","first-page":"3116","DOI":"10.1093\/brain\/awz260","article-title":"Imidazoline 2 binding sites reflecting astroglia pathology in Parkinson\u2019s disease: An in vivo11C-BU99008 PET study","volume":"142","author":"Wilson","year":"2019","journal-title":"Brain"},{"key":"ref_282","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1006\/mcne.2002.1185","article-title":"Macrophages and Microglia Produce Local Trophic Gradients That Stimulate Axonal Sprouting Toward but Not beyond the Wound Edge","volume":"21","author":"Batchelor","year":"2002","journal-title":"Mol. Cell. Neurosci."},{"key":"ref_283","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0163-7258(94)00047-7","article-title":"Astroglial neurotrophic and neurite-promoting factors","volume":"65","author":"Muller","year":"1995","journal-title":"Pharmacol. Ther."},{"key":"ref_284","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.omtn.2022.05.037","article-title":"Suppression of abnormal alpha-synuclein expression by activation of BDNF transcription ameliorates Parkinson\u2019s disease-like pathology","volume":"29","author":"Cao","year":"2022","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"ref_285","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.bbi.2022.09.002","article-title":"Transfer of neuron-derived alpha-synuclein to astrocytes induces neuroinflammation and blood-brain barrier damage after methamphetamine exposure: Involving the regulation of nuclear receptor-associated protein 1","volume":"106","author":"Huang","year":"2022","journal-title":"Brain Behav. Immun."},{"key":"ref_286","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1007\/s10571-010-9523-y","article-title":"Overexpression of alpha-synuclein down-regulates BDNF expression","volume":"30","author":"Yuan","year":"2010","journal-title":"Cell. Mol. Neurobiol."},{"key":"ref_287","doi-asserted-by":"crossref","first-page":"163ra156","DOI":"10.1126\/scitranslmed.3004676","article-title":"Alpha-Synuclein-induced down-regulation of Nurr1 disrupts GDNF signaling in nigral dopamine neurons","volume":"4","author":"Decressac","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"ref_288","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0304-3940(99)00463-2","article-title":"Brain-derived growth factor and nerve growth factor concentrations are decreased in the substantia nigra in Parkinson\u2019s disease","volume":"270","author":"Mogi","year":"1999","journal-title":"Neurosci. Lett."},{"key":"ref_289","doi-asserted-by":"crossref","unstructured":"Riederer, P., Calne, D.B., Horowski, R., Mizuno, Y., Olanow, C.W., Poewe, W., and Youdim, M.B.H. (2000). Changes in cytokines and neurotrophins in Parkinson\u2019s disease. Advances in Research on Neurodegeneration, Springer. Journal of Neural Transmission. Supplementa.","DOI":"10.1007\/978-3-7091-6301-6"},{"key":"ref_290","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0891-0618(01)00115-6","article-title":"Depletion of glial cell line-derived neurotrophic factor in substantia nigra neurons of Parkinson\u2019s disease brain","volume":"21","author":"Chauhan","year":"2001","journal-title":"J. Chem. Neuroanat."},{"key":"ref_291","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/373335a0","article-title":"Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo","volume":"373","author":"Tomac","year":"1995","journal-title":"Nature"},{"key":"ref_292","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/0006-8993(95)01513-2","article-title":"NGF, BDNF and NT-5, but not NT-3 protect against MPP+ toxicity and oxidative stress in neonatal animals","volume":"713","author":"Kirschner","year":"1996","journal-title":"Brain Res."},{"key":"ref_293","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0006-8993(98)01244-X","article-title":"GDNF improves dopamine function in the substantia nigra but not the putamen of unilateral MPTP-lesioned rhesus monkeys","volume":"817","author":"Gerhardt","year":"1999","journal-title":"Brain Res."},{"key":"ref_294","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.neulet.2006.11.017","article-title":"GDNF reduces oxidative stress in a 6-hydroxydopamine model of Parkinson\u2019s disease","volume":"412","author":"Smith","year":"2007","journal-title":"Neurosci. Lett."},{"key":"ref_295","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1006\/exnr.1997.6436","article-title":"Intracerebroventricular glial cell line-derived neurotrophic factor improves motor function and supports nigrostriatal dopamine neurons in bilaterally 6-hydroxydopamine lesioned rats","volume":"145","author":"Bowenkamp","year":"1997","journal-title":"Exp. Neurol."},{"key":"ref_296","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0306-4522(97)83045-X","article-title":"Glial cell line-derived neurotrophic factor attenuates behavioural deficits and regulates nigrostriatal dopaminergic and peptidergic markers in 6-hydroxydopamine-lesioned adult rats: Comparison of intraventricular and intranigral delivery","volume":"78","author":"Lapchak","year":"1997","journal-title":"Neuroscience"},{"key":"ref_297","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/1750-1326-6-49","article-title":"A Wnt1 regulated Frizzled-1\/beta-Catenin signaling pathway as a candidate regulatory circuit controlling mesencephalic dopaminergic neuron-astrocyte crosstalk: Therapeutical relevance for neuron survival and neuroprotection","volume":"6","author":"Serapide","year":"2011","journal-title":"Mol. Neurodegener."},{"key":"ref_298","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.nbd.2010.10.023","article-title":"Reactive astrocytes and Wnt\/beta-catenin signaling link nigrostriatal injury to repair in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson\u2019s disease","volume":"41","author":"Tirolo","year":"2011","journal-title":"Neurobiol. Dis."},{"key":"ref_299","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s40035-020-00190-6","article-title":"Human iPSCs derived astrocytes rescue rotenone-induced mitochondrial dysfunction and dopaminergic neurodegeneration in vitro by donating functional mitochondria","volume":"9","author":"Cheng","year":"2020","journal-title":"Transl. Neurodegener."},{"key":"ref_300","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.bbi.2019.07.009","article-title":"Kir6.1\/K-ATP channel on astrocytes protects against dopaminergic neurodegeneration in the MPTP mouse model of Parkinson\u2019s disease via promoting mitophagy","volume":"81","author":"Hu","year":"2019","journal-title":"Brain Behav. Immun."},{"key":"ref_301","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s40035-021-00262-1","article-title":"Astrocytes and retrograde degeneration of nigrostriatal dopaminergic neurons in Parkinson\u2019s disease: Removing axonal debris","volume":"10","author":"Morales","year":"2021","journal-title":"Transl. Neurodegener."},{"key":"ref_302","doi-asserted-by":"crossref","first-page":"6237","DOI":"10.1038\/s41467-021-26519-x","article-title":"Microglia-specific overexpression of alpha-synuclein leads to severe dopaminergic neurodegeneration by phagocytic exhaustion and oxidative toxicity","volume":"12","author":"Bido","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_303","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/s41419-019-1404-9","article-title":"Microglia as modulators of exosomal alpha-synuclein transmission","volume":"10","author":"Xia","year":"2019","journal-title":"Cell Death Dis."},{"key":"ref_304","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1097\/00001756-200107030-00028","article-title":"Expression of alpha-synuclein in a human glioma cell line and its up-regulation by interleukin-1beta","volume":"12","author":"Tanji","year":"2001","journal-title":"NeuroReport"},{"key":"ref_305","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1523\/JNEUROSCI.1871-20.2020","article-title":"Alpha-Synuclein Oligomers Induce Glutamate Release from Astrocytes and Excessive Extrasynaptic NMDAR Activity in Neurons, Thus Contributing to Synapse Loss","volume":"41","author":"Trudler","year":"2021","journal-title":"J. Neurosci."},{"key":"ref_306","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1212\/WNL.58.2.308","article-title":"FADD. A link between TNF family receptors and caspases in Parkinson\u2019s disease","volume":"58","author":"Hartmann","year":"2002","journal-title":"Neurology"},{"key":"ref_307","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0304-3940(94)90684-X","article-title":"Immunocytochemical analysis of tumor necrosis factor and its receptors in Parkinson\u2019s disease","volume":"172","author":"Boka","year":"1994","journal-title":"Neurosci. Lett."},{"key":"ref_308","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/0304-3940(94)90746-3","article-title":"Tumor necrosis factor-alpha (TNF-alpha) increases both in the brain and in the cerebrospinal fluid from parkinsonian patients","volume":"165","author":"Mogi","year":"1994","journal-title":"Neurosci. Lett."},{"key":"ref_309","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/BF02252965","article-title":"Brain beta 2-microglobulin levels are elevated in the striatum in Parkinson\u2019s disease","volume":"9","author":"Mogi","year":"1995","journal-title":"J. Neural Transm. Park. Dis. Dement. Sect."},{"key":"ref_310","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0304-3940(01)02111-5","article-title":"Tumor necrosis factor gene polymorphisms in patients with sporadic Parkinson\u2019s disease","volume":"311","author":"Nishimura","year":"2001","journal-title":"Neurosci. Lett."},{"key":"ref_311","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s007020050028","article-title":"Caspase activities and tumor necrosis factor receptor, R.1 (p55) level are elevated in the substantia nigra from parkinsonian brain","volume":"107","author":"Mogi","year":"2000","journal-title":"J. Neural Transm."},{"key":"ref_312","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/j.1749-6632.2003.tb07478.x","article-title":"The role of glial reaction and inflammation in Parkinson\u2019s disease","volume":"991","author":"Hirsch","year":"2003","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_313","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1523\/JNEUROSCI.21-07-02247.2001","article-title":"Caspase-8 is an effector in apoptotic death of dopaminergic neurons in Parkinson\u2019s disease, but pathway inhibition results in neuronal necrosis","volume":"21","author":"Hartmann","year":"2001","journal-title":"J. Neurosci."},{"key":"ref_314","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1096\/fj.02-0216fje","article-title":"Mice deficient in TNF receptors are protected against dopaminergic neurotoxicity: Implications for Parkinson\u2019s disease","volume":"16","author":"Sriram","year":"2002","journal-title":"FASEB J."},{"key":"ref_315","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1111\/j.1471-4159.2005.03566.x","article-title":"Minocycline attenuates microglial activation but fails to mitigate striatal dopaminergic neurotoxicity: Role of tumor necrosis factor-alpha","volume":"96","author":"Sriram","year":"2006","journal-title":"J. Neurochem."},{"key":"ref_316","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1096\/fj.05-5106com","article-title":"Deficiency of, T.NF receptors suppresses microglial activation and alters the susceptibility of brain regions to, M.PTP-induced neurotoxicity: Role of TNF-alpha","volume":"20","author":"Sriram","year":"2006","journal-title":"FASEB J."},{"key":"ref_317","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1046\/j.1471-4159.2002.00928.x","article-title":"Microglial activation-mediated delayed and progressive degeneration of rat nigral dopaminergic neurons: Relevance to Parkinson\u2019s disease","volume":"81","author":"Gao","year":"2002","journal-title":"J. Neurochem."},{"key":"ref_318","doi-asserted-by":"crossref","first-page":"6145","DOI":"10.1073\/pnas.0937239100","article-title":"NADPH oxidase mediates oxidative stress in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson\u2019s disease","volume":"100","author":"Wu","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_319","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1096\/fj.03-0983fje","article-title":"Neuroprotective effect of dextromethorphan in the MPTP Parkinson\u2019s disease model: Role of NADPH oxidase","volume":"18","author":"Zhang","year":"2004","journal-title":"FASEB J."},{"key":"ref_320","doi-asserted-by":"crossref","first-page":"3440","DOI":"10.1523\/JNEUROSCI.19-09-03440.1999","article-title":"FcepsilonRII\/CD23 is expressed in Parkinson\u2019s disease and induces, in vitro, production of nitric oxide and tumor necrosis factor-alpha in glial cells","volume":"19","author":"Hunot","year":"1999","journal-title":"J. Neurosci."},{"key":"ref_321","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1097\/00019052-200108000-00009","article-title":"The role of glial cells in Parkinson\u2019s disease","volume":"14","author":"Vila","year":"2001","journal-title":"Curr. Opin. Neurol."},{"key":"ref_322","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1097\/00001756-199508000-00013","article-title":"Increased cerebrospinal fluid concentration of nitrite in Parkinson\u2019s disease","volume":"6","author":"Qureshi","year":"1995","journal-title":"NeuroReport"},{"key":"ref_323","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1097\/00005072-199804000-00006","article-title":"Protein nitration in Parkinson\u2019s disease","volume":"57","author":"Good","year":"1998","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"ref_324","doi-asserted-by":"crossref","first-page":"14232","DOI":"10.18632\/aging.103440","article-title":"Minocycline inhibition of microglial rescues nigrostriatal dopaminergic neurodegeneration caused by mutant alpha-synuclein overexpression","volume":"12","author":"Wang","year":"2020","journal-title":"Aging"},{"key":"ref_325","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1523\/JNEUROSCI.22-05-01763.2002","article-title":"Blockade of microglial activation is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson disease","volume":"22","author":"Wu","year":"2002","journal-title":"J. Neurosci."},{"key":"ref_326","doi-asserted-by":"crossref","first-page":"101890","DOI":"10.1016\/j.pneurobio.2020.101890","article-title":"Ferroptosis and its potential role in the physiopathology of Parkinson\u2019s Disease","volume":"196","author":"Bouchaoui","year":"2021","journal-title":"Prog. Neurobiol."},{"key":"ref_327","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.tcb.2015.10.014","article-title":"Ferroptosis: Death by Lipid Peroxidation","volume":"26","author":"Yang","year":"2016","journal-title":"Trends Cell Biol."},{"key":"ref_328","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","article-title":"Ferroptosis: An iron-dependent form of nonapoptotic cell death","volume":"149","author":"Dixon","year":"2012","journal-title":"Cell"},{"key":"ref_329","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.molmed.2022.02.003","article-title":"Ferroptosis in Parkinson\u2019s disease: Glia-neuron crosstalk","volume":"28","author":"Wang","year":"2022","journal-title":"Trends Mol. Med."},{"key":"ref_330","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s004010050001","article-title":"Sequestration of iron by Lewy bodies in Parkinson\u2019s disease","volume":"100","author":"Castellani","year":"2000","journal-title":"Acta Neuropathol."},{"key":"ref_331","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/s41419-020-03369-x","article-title":"Intranasal administration of alpha-synuclein preformed fibrils triggers microglial iron deposition in the substantia nigra of Macaca fascicularis","volume":"12","author":"Guo","year":"2021","journal-title":"Cell Death Dis."},{"key":"ref_332","doi-asserted-by":"crossref","first-page":"16116","DOI":"10.1074\/jbc.M107866200","article-title":"Magnesium inhibits spontaneous and iron-induced aggregation of alpha-synuclein","volume":"277","author":"Golts","year":"2002","journal-title":"J. Biol. Chem."},{"key":"ref_333","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1097\/WNR.0b013e328354a1f0","article-title":"\u03b1-Synuclein expression is modulated at the translational level by iron","volume":"23","author":"Febbraro","year":"2012","journal-title":"NeuroReport"},{"key":"ref_334","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.bbagen.2008.12.001","article-title":"Amyloid precursor protein and alpha synuclein translation, implications for iron and inflammation in neurodegenerative diseases","volume":"1790","author":"Cahill","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_335","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.1038\/s41418-020-0542-z","article-title":"Alpha synuclein aggregation drives ferroptosis: An interplay of iron, calcium and lipid peroxidation","volume":"27","author":"Angelova","year":"2020","journal-title":"Cell Death Differ."},{"key":"ref_336","doi-asserted-by":"crossref","first-page":"4628","DOI":"10.1007\/s12035-020-02049-3","article-title":"Activation of p62-Keap1-Nrf2 Pathway Protects 6-Hydroxydopamine-Induced Ferroptosis in Dopaminergic Cells","volume":"57","author":"Sun","year":"2020","journal-title":"Mol. Neurobiol."},{"key":"ref_337","doi-asserted-by":"crossref","first-page":"17013","DOI":"10.1038\/cddiscovery.2017.13","article-title":"MPP plus induces necrostatin-1-and ferrostatin-1-sensitive necrotic death of neuronal SH-SY5Y cells","volume":"3","author":"Ito","year":"2017","journal-title":"Cell Death Discov."},{"key":"ref_338","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.nbd.2016.05.011","article-title":"Ferroptosis, a newly characterized form of cell death in Parkinson\u2019s disease that is regulated by PKC","volume":"94","author":"Gouel","year":"2016","journal-title":"Neurobiol. Dis."},{"key":"ref_339","doi-asserted-by":"crossref","first-page":"3187","DOI":"10.1007\/s12035-021-02320-1","article-title":"Thioredoxin-1 Rescues MPP(+)\/MPTP-Induced Ferroptosis by Increasing Glutathione Peroxidase 4","volume":"58","author":"Bai","year":"2021","journal-title":"Mol. Neurobiol."},{"key":"ref_340","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1038\/s41467-020-15065-7","article-title":"Analysis of DNA methylation associates the cystine-glutamate antiporter SLC7A11 with risk of Parkinson\u2019s disease","volume":"11","author":"Vallerga","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_341","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0896-6273(00)80953-8","article-title":"A role for 12-lipoxygenase in nerve cell death caused by glutathione depletion","volume":"19","author":"Li","year":"1997","journal-title":"Neuron"},{"key":"ref_342","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.freeradbiomed.2016.10.490","article-title":"Role of 4-hydroxy-2-nonenal (HNE) in the pathogenesis of alzheimer disease and other selected age-related neurodegenerative disorders","volume":"111","author":"Tramutola","year":"2017","journal-title":"Free Radic. Biol. Med."},{"key":"ref_343","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1038\/s41467-020-15109-y","article-title":"DJ-1 suppresses ferroptosis through preserving the activity of S-adenosyl homocysteine hydrolase","volume":"11","author":"Cao","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_344","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1212\/01.wnl.0000262033.01945.9a","article-title":"Individual dopaminergic neurons show raised iron levels in Parkinson disease","volume":"68","author":"Oakley","year":"2007","journal-title":"Neurology"},{"key":"ref_345","doi-asserted-by":"crossref","first-page":"111231","DOI":"10.1016\/j.celrep.2022.111231","article-title":"Alpha synuclein determines ferroptosis sensitivity in dopaminergic neurons via modulation of ether-phospholipid membrane composition","volume":"40","author":"Bouchaoui","year":"2022","journal-title":"Cell Rep."},{"key":"ref_346","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.bbrc.2020.07.032","article-title":"NEDD4L-mediated LTF protein degradation limits ferroptosis","volume":"531","author":"Wang","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_347","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1007\/s13311-020-00929-z","article-title":"FTH1 Inhibits Ferroptosis Through Ferritinophagy in the 6-OHDA Model of Parkinson\u2019s Disease","volume":"17","author":"Tian","year":"2020","journal-title":"Neurotherapeutics"},{"key":"ref_348","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1021\/acschemneuro.0c00196","article-title":"Alpha-Synuclein Regulates Iron Homeostasis via Preventing Parkin-Mediated DMT1 Ubiquitylation in Parkinson\u2019s Disease Models","volume":"11","author":"Bi","year":"2020","journal-title":"ACS Chem. Neurosci."},{"key":"ref_349","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.cell.2017.09.021","article-title":"Ferroptosis: A Regulated Cell Death Nexus Linking Metabolism, Redox Biology, and Disease","volume":"171","author":"Stockwell","year":"2017","journal-title":"Cell"},{"key":"ref_350","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.freeradbiomed.2018.03.001","article-title":"Selenium and GPX4, a vital symbiosis","volume":"127","author":"Angeli","year":"2018","journal-title":"Free Radic. Biol. Med."},{"key":"ref_351","doi-asserted-by":"crossref","first-page":"776","DOI":"10.3389\/fnins.2020.00776","article-title":"Cross Talk between Ferroptosis and Cerebral Ischemia","volume":"14","author":"She","year":"2020","journal-title":"Front. Neurosci.-Switz."},{"key":"ref_352","doi-asserted-by":"crossref","first-page":"103413","DOI":"10.1016\/j.mcn.2019.103413","article-title":"Crosstalk between Nrf2 signaling and mitochondrial function in Parkinson\u2019s disease","volume":"101","author":"Kaidery","year":"2019","journal-title":"Mol. Cell. Neurosci."},{"key":"ref_353","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/nen.0b013e31802d6da9","article-title":"Expression of Nrf2 in neurodegenerative diseases","volume":"66","author":"Ramsey","year":"2007","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"ref_354","doi-asserted-by":"crossref","first-page":"7237","DOI":"10.1007\/s12035-015-9582-7","article-title":"Expression of Iron-Related Proteins at the Neurovascular Unit Supports Reduction and Reoxidation of Iron for Transport Through the Blood-Brain Barrier","volume":"53","author":"Burkhart","year":"2016","journal-title":"Mol. Neurobiol."},{"key":"ref_355","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1002\/jbt.21803","article-title":"Ferrous Iron Induces Nrf2 Expression in Mouse Brain Astrocytes to Prevent Neurotoxicity","volume":"30","author":"Cui","year":"2016","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"ref_356","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.chembiol.2020.03.007","article-title":"The chemical biology of ferroptosis in the central nervous system","volume":"27","author":"Ratan","year":"2020","journal-title":"Cell Chem. Biol."},{"key":"ref_357","first-page":"19","article-title":"Divalent metal transporter 1 (DMT1) in the brain: Implications for a role in iron transport at the blood-brain barrier, and neuronal and glial pathology","volume":"8","author":"Skjorringe","year":"2015","journal-title":"Front. Mol. Neurosci."},{"key":"ref_358","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3389\/fncel.2020.00051","article-title":"Ischemia-Triggered Glutamate Excitotoxicity From the Perspective of Glial Cells","volume":"14","author":"Kriska","year":"2020","journal-title":"Front. Cell. Neurosci."},{"key":"ref_359","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/nrneurol.2014.118","article-title":"Iron in multiple sclerosis: Roles in neurodegeneration and repair","volume":"10","author":"Stephenson","year":"2014","journal-title":"Nat. Rev. Neurol."},{"key":"ref_360","doi-asserted-by":"crossref","unstructured":"Lim, J.L., van der Pol, S.M., Baron, W., McCord, J.M., de Vries, H.E., and van Horssen, J. (2016). Protandim Protects Oligodendrocytes against an Oxidative Insult. Antioxidants, 5.","DOI":"10.3390\/antiox5030030"},{"key":"ref_361","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.cmet.2020.05.019","article-title":"Oligodendrocytes Provide Antioxidant Defense Function for Neurons by Secreting Ferritin Heavy Chain","volume":"32","author":"Mukherjee","year":"2020","journal-title":"Cell Metab."},{"key":"ref_362","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.parkreldis.2017.01.003","article-title":"Iron accumulation and microglia activation contribute to substantia nigra hyperechogenicity in the 6-OHDA-induced rat model of Parkinson\u2019s disease","volume":"36","author":"Zhu","year":"2017","journal-title":"Park. Relat. Disord."},{"key":"ref_363","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1194\/jlr.M080374","article-title":"Acid sphingomyelinase promotes mitochondrial dysfunction due to glutamate-induced regulated necrosis","volume":"59","author":"Novgorodov","year":"2018","journal-title":"J. Lipid Res."},{"key":"ref_364","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/j.neuron.2014.07.027","article-title":"TNF and increased intracellular iron alter macrophage polarization to a detrimental M1 phenotype in the injured spinal cord","volume":"83","author":"Kroner","year":"2014","journal-title":"Neuron"},{"key":"ref_365","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.bbadis.2013.01.021","article-title":"Pro-inflammatory cytokines modulate iron regulatory protein 1 expression and iron transportation through reactive oxygen\/nitrogen species production in ventral mesencephalic neurons","volume":"1832","author":"Wang","year":"2013","journal-title":"Biochim. Biophys. Acta (BBA)-Mol. Basis Dis."},{"key":"ref_366","doi-asserted-by":"crossref","first-page":"3326","DOI":"10.1007\/s12035-015-9267-2","article-title":"Apocyanin, a Microglial NADPH Oxidase Inhibitor Prevents Dopaminergic Neuronal Degeneration in Lipopolysaccharide-Induced Parkinson\u2019s Disease Model","volume":"53","author":"Sharma","year":"2016","journal-title":"Mol. Neurobiol."},{"key":"ref_367","doi-asserted-by":"crossref","first-page":"455","DOI":"10.3389\/fnmol.2017.00455","article-title":"New Progress on the Role of Glia in Iron Metabolism and Iron-Induced Degeneration of Dopamine Neurons in Parkinson\u2019s Disease","volume":"10","author":"Xu","year":"2018","journal-title":"Front. Mol. Neurosci."},{"key":"ref_368","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/s41589-019-0462-8","article-title":"Redox lipid reprogramming commands susceptibility of macrophages and microglia to ferroptotic death","volume":"16","author":"Kapralov","year":"2020","journal-title":"Nat. Chem. Biol."},{"key":"ref_369","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1182\/blood-2017-02-768580","article-title":"Ferritin is secreted via 2 distinct nonclassical vesicular pathways","volume":"131","author":"Berenbaum","year":"2018","journal-title":"Blood"},{"key":"ref_370","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.devcel.2019.10.007","article-title":"Prominin2 Drives Ferroptosis Resistance by Stimulating Iron Export","volume":"51","author":"Brown","year":"2019","journal-title":"Dev. Cell"},{"key":"ref_371","doi-asserted-by":"crossref","first-page":"4695","DOI":"10.1096\/fj.14-268615","article-title":"Intercellular transfer of transferrin receptor by a contact-, Rab8-dependent mechanism involving tunneling nanotubes","volume":"29","author":"Burtey","year":"2015","journal-title":"FASEB J."},{"key":"ref_372","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s13311-013-0196-3","article-title":"Prion-like propagation of protein aggregation and related therapeutic strategies","volume":"10","author":"Kaufman","year":"2013","journal-title":"Neurotherapeutics"},{"key":"ref_373","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1126\/science.aaf3934","article-title":"\u03b22-Adrenoreceptor is a regulator of the alpha-synuclein gene driving risk of Parkinson\u2019s disease","volume":"357","author":"Mittal","year":"2017","journal-title":"Science"},{"key":"ref_374","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1007\/s11481-018-09831-0","article-title":"Beta2-Adrenoceptor Agonists in Parkinson\u2019s Disease and Other Synucleinopathies","volume":"15","author":"Magistrelli","year":"2020","journal-title":"J. Neuroimmune Pharmacol."},{"key":"ref_375","doi-asserted-by":"crossref","first-page":"105543","DOI":"10.1016\/j.nbd.2021.105543","article-title":"ABBV-0805, a novel antibody selective for soluble aggregated alpha-synuclein, prolongs lifespan and prevents buildup of alpha-synuclein pathology in mouse models of Parkinson\u2019s disease","volume":"161","author":"Nordstrom","year":"2021","journal-title":"Neurobiol. Dis."},{"key":"ref_376","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.nbd.2014.05.009","article-title":"Immunotherapy targeting alpha-synuclein protofibrils reduced pathology in (Thy-1)-h[A30P] alpha-synuclein mice","volume":"69","author":"Lindstrom","year":"2014","journal-title":"Neurobiol. Dis."},{"key":"ref_377","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.cger.2019.09.012","article-title":"Depression and Anxiety in Parkinson Disease","volume":"36","author":"Ray","year":"2020","journal-title":"Clin. Geriatr. Med."},{"key":"ref_378","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1001\/2013.jamaneurol.45","article-title":"History, applications, and mechanisms of deep brain stimulation","volume":"70","author":"Miocinovic","year":"2013","journal-title":"JAMA Neurol."},{"key":"ref_379","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1056\/NEJMct1208070","article-title":"Deep-Brain Stimulation for Parkinson\u2019s Disease","volume":"367","author":"Okun","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"ref_380","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/mt.2013.281","article-title":"Parkinson\u2019s disease gene therapy: Success by design meets failure by efficacy","volume":"22","author":"Bartus","year":"2014","journal-title":"Mol. Ther."},{"key":"ref_381","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/nrneurol.2015.123","article-title":"Cell-based therapies for Parkinson disease-past insights and future potential","volume":"11","author":"Barker","year":"2015","journal-title":"Nat. Rev. Neurol."},{"key":"ref_382","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/joim.12415","article-title":"Clinical translation of stem cell transplantation in Parkinson\u2019s disease","volume":"279","author":"Lindvall","year":"2016","journal-title":"J. Intern. Med."},{"key":"ref_383","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1097\/WCO.0b013e32833b1f62","article-title":"Cell transplantation in Parkinson\u2019s disease: Problems and perspectives","volume":"23","author":"Allan","year":"2010","journal-title":"Curr. Opin. Neurol."},{"key":"ref_384","doi-asserted-by":"crossref","first-page":"3993","DOI":"10.1002\/1873-3468.12906","article-title":"Mechanisms of radial glia progenitor cell lineage progression","volume":"591","author":"Beattie","year":"2017","journal-title":"FEBS Lett."},{"key":"ref_385","first-page":"571475","article-title":"Potential of Neural Stem Cell-Based Therapy for Parkinson\u2019s Disease","volume":"2015","author":"Chou","year":"2015","journal-title":"Park. Dis."},{"key":"ref_386","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1056\/NEJM199810083391506","article-title":"Parkinson\u2019s disease: First of two parts","volume":"339","author":"Lang","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"ref_387","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.autrev.2016.07.022","article-title":"Parkinson\u2019s disease: Autoimmunity and neuroinflammation","volume":"15","author":"Greco","year":"2016","journal-title":"Autoimmun. Rev."},{"key":"ref_388","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.it.2008.05.002","article-title":"Why neurodegenerative diseases are progressive: Uncontrolled inflammation drives disease progression","volume":"29","author":"Gao","year":"2008","journal-title":"Trends Immunol."},{"key":"ref_389","doi-asserted-by":"crossref","unstructured":"Badanjak, K., Fixemer, S., Smajic, S., Skupin, A., and Grunewald, A. (2021). The Contribution of Microglia to Neuroinflammation in Parkinson\u2019s Disease. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22094676"},{"key":"ref_390","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.1600-0404.1999.tb00721.x","article-title":"Association of circulating TNF-alpha and IL-6 with ageing and parkinsonism","volume":"100","author":"Dobbs","year":"1999","journal-title":"Acta Neurol. Scand."},{"key":"ref_391","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1038\/s41586-018-0448-9","article-title":"Parkin and PINK1 mitigate STING-induced inflammation","volume":"561","author":"Sliter","year":"2018","journal-title":"Nature"},{"key":"ref_392","doi-asserted-by":"crossref","first-page":"3041","DOI":"10.1093\/brain\/awaa246","article-title":"Mitochondrial damage-associated inflammation highlights biomarkers in PRKN\/PINK1 parkinsonism","volume":"143","author":"Borsche","year":"2020","journal-title":"Brain"},{"key":"ref_393","first-page":"474","article-title":"The role of inflammatory cytokines in cognition and other non-motor symptoms of Parkinson\u2019s disease","volume":"51","author":"Menza","year":"2010","journal-title":"Psychosomatics"},{"key":"ref_394","doi-asserted-by":"crossref","unstructured":"Lindqvist, D., Kaufman, E., Brundin, L., Hall, S., Surova, Y., and Hansson, O. (2012). Non-motor symptoms in patients with Parkinson\u2019s disease-correlations with inflammatory cytokines in serum. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0047387"},{"key":"ref_395","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.neuroscience.2017.10.018","article-title":"Neuroprotective and Neuro-restorative Effects of Minocycline and Rasagiline in a Zebrafish 6-Hydroxydopamine Model of Parkinson\u2019s Disease","volume":"367","author":"Cronin","year":"2017","journal-title":"Neuroscience"},{"key":"ref_396","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.neuro.2017.03.002","article-title":"Minocycline protects, rescues and prevents knockdown transgenic parkin Drosophila against paraquat\/iron toxicity: Implications for autosomic recessive juvenile parkinsonism","volume":"60","year":"2017","journal-title":"Neurotoxicology"},{"key":"ref_397","doi-asserted-by":"crossref","first-page":"6843265","DOI":"10.1155\/2019\/6843265","article-title":"Minocycline Protects against Rotenone-Induced Neurotoxicity Correlating with Upregulation of Nurr1 in a Parkinson\u2019s Disease Rat Model","volume":"2019","author":"Sun","year":"2019","journal-title":"BioMed Res. Int."},{"key":"ref_398","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.nbd.2008.11.013","article-title":"Minocycline restores striatal tyrosine hydroxylase in GDNF heterozygous mice but not in methamphetamine-treated mice","volume":"33","author":"Boger","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"ref_399","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1212\/01.wnl.0000201252.57661.e1","article-title":"A randomized, double-blind, futility clinical trial of creatine and minocycline in early Parkinson disease","volume":"66","author":"Investigators","year":"2006","journal-title":"Neurology"},{"key":"ref_400","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/WNF.0b013e3181342f32","article-title":"A pilot clinical trial of creatine and minocycline in early Parkinson disease: 18-month results","volume":"31","author":"Investigators","year":"2008","journal-title":"Clin. Neuropharmacol."},{"key":"ref_401","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/jnr.10709","article-title":"Minocycline enhances MPTP toxicity to dopaminergic neurons","volume":"74","author":"Yang","year":"2003","journal-title":"J. Neurosci. Res."},{"key":"ref_402","doi-asserted-by":"crossref","first-page":"3266","DOI":"10.1111\/j.0953-816X.2004.03372.x","article-title":"Deleterious effects of minocycline in animal models of Parkinson\u2019s disease and Huntington\u2019s disease","volume":"19","author":"Diguet","year":"2004","journal-title":"Eur. J. Neurosci."},{"key":"ref_403","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.neuroscience.2019.06.006","article-title":"Glatiramer Acetate Reverses Motor Dysfunction and the Decrease in Tyrosine Hydroxylase Levels in a Mouse Model of Parkinson\u2019s Disease","volume":"414","author":"Churchill","year":"2019","journal-title":"Neuroscience"},{"key":"ref_404","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/nbt.3835","article-title":"Induction of functional dopamine neurons from human astrocytes in vitro and mouse astrocytes in a Parkinson\u2019s disease model","volume":"35","author":"Romanov","year":"2017","journal-title":"Nat. Biotechnol."},{"key":"ref_405","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1016\/j.stemcr.2017.05.011","article-title":"Differentiation of Inflammation-Responsive Astrocytes from Glial Progenitors Generated from Human Induced Pluripotent Stem Cells","volume":"8","author":"Santos","year":"2017","journal-title":"Stem Cell Rep."},{"key":"ref_406","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1038\/nprot.2011.405","article-title":"Directed differentiation of functional astroglial subtypes from human pluripotent stem cells","volume":"6","author":"Krencik","year":"2011","journal-title":"Nat. Protoc."},{"key":"ref_407","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1089\/ars.2013.5593","article-title":"Targeting chelatable iron as a therapeutic modality in Parkinson\u2019s disease","volume":"21","author":"Devos","year":"2014","journal-title":"Antioxid. Redox Signal."},{"key":"ref_408","doi-asserted-by":"crossref","first-page":"508","DOI":"10.4103\/1673-5374.320973","article-title":"One ring is sufficient to inhibit \u03b1-synuclein aggregation","volume":"17","author":"Ventura","year":"2022","journal-title":"Neural Regen. Res."},{"key":"ref_409","doi-asserted-by":"crossref","first-page":"996217","DOI":"10.3389\/fnagi.2022.996217","article-title":"Nilotinib in Parkinson\u2019s disease: A systematic review and meta-analysis","volume":"14","author":"Xie","year":"2022","journal-title":"Front. Aging Neurosci."},{"key":"ref_410","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/psp4.12538","article-title":"Phase II Dose Selection for Alpha Synuclein-Targeting Antibody Cinpanemab (BIIB054) Based on Target Protein Binding Levels in the Brain","volume":"9","author":"Kuchimanchi","year":"2020","journal-title":"CPT Pharmacomet. Syst. Pharmacol."},{"key":"ref_411","doi-asserted-by":"crossref","first-page":"176","DOI":"10.3389\/fnagi.2017.00176","article-title":"Targeting Microglial Activation States as a Therapeutic Avenue in Parkinson\u2019s Disease","volume":"9","author":"Subramaniam","year":"2017","journal-title":"Front. Aging Neurosci."},{"key":"ref_412","doi-asserted-by":"crossref","unstructured":"Valori, C.F., Possenti, A., Brambilla, L., and Rossi, D. (2021). Challenges and Opportunities of Targeting Astrocytes to Halt Neurodegenerative Disorders. Cells, 10.","DOI":"10.3390\/cells10082019"},{"key":"ref_413","doi-asserted-by":"crossref","unstructured":"Perez, B.A., Shutterly, A., Chan, Y.K., Byrne, B.J., and Corti, M. (2020). Management of Neuroinflammatory Responses to AAV-Mediated Gene Therapies for Neurodegenerative Diseases. Brain Sci., 10.","DOI":"10.3390\/brainsci10020119"},{"key":"ref_414","doi-asserted-by":"crossref","first-page":"eabg3198","DOI":"10.1126\/sciadv.abg3198","article-title":"Treating Parkinson\u2019s disease by astrocyte reprogramming: Progress and challenges","volume":"7","author":"Wei","year":"2021","journal-title":"Sci. Adv."},{"key":"ref_415","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1021\/acschemneuro.7b00478","article-title":"Mechanism Underlying the Effectiveness of Deferiprone in Alleviating Parkinson\u2019s Disease Symptoms","volume":"9","author":"Sun","year":"2018","journal-title":"ACS Chem. Neurosci."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/23\/14753\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:26:50Z","timestamp":1760146010000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/23\/14753"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,25]]},"references-count":415,"journal-issue":{"issue":"23","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["ijms232314753"],"URL":"https:\/\/doi.org\/10.3390\/ijms232314753","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,25]]}}}